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ABSTRACT 
 
Streptomycetes, as nonmotile microbes, are forced to adapt to environmental 
conditions they cannot escape.  In order to adapt to their environment streptomycetes 
produce an array of both secondary metabolites to antagonize competitors and 
degradative enzymes to take advantage of various nutritional sources and to degrade 
xenobiotics, molecules from foreign organisms.  This work shows two instances of 
streptomycetes adapting to their neighbors.  Streptomyces sp. Mg1 was determined to be 
resistant to surfactin, a molecule produced by Bacillus subtilis which inhibits aerial 
hyphae development.  After identifying possible enzymatic sources of degradation 
several candidate enzymes were cloned and expressed in Escherichia coli.  One 
candidate, ‘secreted hydrolase’ was purified under denaturing conditions and refolded.  
This enzyme was shown to degrade surfactin and another B. subtilis metabolite, 
plipastatin.  Upon alteration of assay conditions the enzyme was also able to degrade 
daptomycin.  The other instance of a streptomycete adapting to its neighbors is of S. 
coelicolor, which in the presence of some strains of B. subtilis is able to produce 
undecylprodigiosin earlier than it normally would.  The induction of undecylprodigiosin 
indicates that either B. subtilis is altering a neighbor’s physiology through a secreted 
compound or that S. coelicolor is able to detect a xenobiotic and responds by producing 
an antibiotic compound.  The inducing compound from B. subtilis was fractionated and 
conditions for its further purification were determined. 
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CHAPTER I  
 
INTRODUCTION 
 
With antibiotic-resistant infections causing health care costs of $20 billion in the 
United States alone there is an urgent need for new antibacterial agents (Bush, et al., 
2011).  More than half of all bacterial infections are due to pathogens with one or more 
drug resistances (Demain, 2009).  Soil bacteria from the actinomycete family are the 
dominant producers of commercially available antibiotics producing over 90% of 
practically used antibiotics (Hamaki, et al., 2005, Tiwari & Gupta, 2012), with the 
remainder mostly coming from fungi (Baltz, 2006).  The Streptomyces genus within 
actinobacteria is responsible for most antibiotics produced from actinomycetes (Baltz, 
2006).  Streptomycetes have been extensively mined for antibiotics; they yielded 75 new 
antibiotics per year from 1960-1980, which diminished to 20 per year between 1980 and 
2000 as the discovery rate of ‘new’ compounds declined (Baltz, 2006).  Genome mining 
of streptomycetes has revealed a vast potential untapped by traditional fermentation, 
despite many different strategies increase production (Corre, et al., 2008).  We have tried 
a relatively new approach to understand antibiotic production wherein we co-culture 
streptomycetes with another organism.  This will allow us to better understand the roles 
of antibiotics in nature and possible triggers. 
The decreased rate of antibiotic discovery has many causes, reaching all the ‘low 
hanging fruit’ of easily attainable antibiotics (Tiwari & Gupta, 2012), the rediscovery of 
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known compounds which causes the need to screen more organisms (Baltz, 2006), as 
well as waning research budgets as pharmaceutical companies have shifted their focus 
towards more marketable drugs (Vicente, et al., 2006).   The advent of large-scale 
combinatorial chemistry and high-throughput screening libraries has further driven drug 
companies away from traditional natural product discovery (Baltz, 2008).  However, 
more than half of the ‘new chemical entities,’ compounds with novel motifs, discovered 
since 1981 came from natural products (Newman & Cragg, 2007).  The advantages of 
natural products as antibiotics, compared to synthesized molecules, range from their 
scaffold diversity to a high tolerance of functional groups to a much higher occurrence 
of novel motifs (Ganesan, 2008).  Natural products also have an advantage over 
synthesized compounds in that they have evolved over ~1 billion years for bioactivity 
(Baltz, 2008).  Of the 1184 new chemical entities described by Newman and Cragg from 
1981-2006, 52% had a natural product connection.   
 Within actinomycetes, the genus Streptomyces stands as a source of novel 
molecules, with two thirds of all commercial antibiotics derived from Streptomyces 
secondary metabolites (Bibb & Hesketh, 2009).  Genome mining of streptomycetes has 
shown that the secondary metabolic genetic potential of Streptomyces is largely 
untapped in the laboratory setting (Corre, et al., 2008).  Sequenced streptomycetes have 
at least 20 and sometimes up to 30 gene clusters predicted to encode for secondary 
metabolites (Baltz, 2011), the vast majority of which are not detected due to insensitive 
screening techniques (Baltz, 2008, Davies, 2010).  Standard fermentation broth 
screening apparently lacks the chemical or physical signals needed to express most 
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metabolite gene clusters (Zazopoulos, et al., 2003).  This latent genetic potential, for 
“cryptic metabolites,” occupies a large amount of streptomycete genomes, in the larger 
genomes 5-10% (Baltz, 2008).  Secondary metabolites are often highly conserved within 
strains of an organism, giving credence to the idea that these metabolites confer an 
adaptive advantage (Borodina, et al., 2005).  In S. coelicolor at least 23 secondary 
metabolite gene clusters occupy 5% of the 8.7MB genome (Bentley, et al., 2002).  Only 
6 metabolites have been isolated, four antibiotics: methylenomycin A, calcium-
dependent antibiotic, undecylprodigiosin and actinorhodin; as well as two other 
molecules: coelichelin, a new siderophore (Challis, 2008, Xu, et al., 2010), and a group 
of molecules, germicidins, which inhibit spore germination (Aoki, et al., 2011).  Varying 
conditions to mimic environment cues have been used in traditional fermentation 
screenings to “awaken” the cryptic gene clusters responsible for secondary metabolism.   
Traditional approaches include altering nutrient sources (Martin, et al., 2011), 
over-expressing activators (Baltz, 2010), deleting putative negative regulators (Gottelt, 
et al., 2010), an extensive amount of single gene knockouts (Castro-Melchor, et al., 
2010), heterologous expression of cryptic gene clusters (Widdick, et al., 2003), 
transposon mutagenesis to either knockout or up regulate various genes (Bibb & 
Hesketh, 2009), making multiple copies of a particular gene cluster within a genome 
(Murakami, et al., 2011), knocking out other secondary metabolite gene clusters which 
compete for precursors (Komatsu, et al., 2010, Gomez-Escribano & Bibb, 2011), or 
mutagenizing the genome to get higher yields (Inaoka, et al., 2004, Wang, et al., 2008, 
Inaoka & Ochi, 2011).  Secondary metabolites come from the redirection of 
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intermediaries in primary metabolism into alternative pathways (Murakami, et al., 
2011).  Thus another approach has been to chemically stimulate various streptomycetes 
so their primary metabolism is perturbed in such a way that some secondary metabolism 
is altered or increased (Craney, et al., 2012). 
An alternative way of studying secondary metabolism has been to induce a 
metabolic shift by perturbing one organism with another.  This co-culture method has 
been used to put stress upon an organism, which could occur in the environment but 
would not otherwise occur in a laboratory.  There are tens of studies showing induction 
of secondary metabolism in fungi and bacteria due to co-culture stress (Patterson & 
Bolis, 1997, Burgess, et al., 1999, Ueda, et al., 2000, Cueto, et al., 2001, Onaka, et al., 
2001, Santamaria, et al., 2002, Trischman, et al., 2004, Yamanaka, et al., 2005, Angell, 
et al., 2006, Miao, et al., 2006, Oh, et al., 2007, Siemieniewicz & Schrempf, 2007, 
Schroeckh, et al., 2009, Amano, et al., 2010, Li, et al., 2010, Liu, et al., 2010, Amano, et 
al., 2011, Li, et al., 2011, Luti & Mavituna, 2011, Luti & Mavituna, 2011, Onaka, et al., 
2011, Perez, et al., 2011, Zuck, et al., 2011, Traxler, et al., 2012).  The most abundant 
studies pair marine microbes together to see induction of a metabolite absent in 
monoculture or either strain.  Among the studies that focus on streptomycetes there is a 
similar pattern, for instance Ueda et al. showed, that from 45 fresh soil isolates of 
streptomycetes, 98% either increased antibiotic production or triggered early sporulation 
in other streptomycetes (Ueda, et al., 2000).  These studies show that bacteria can and do 
interact with their neighbors by triggering or responding to chemical stressors, however, 
there is little mechanistic evidence for the basis of induction of secondary metabolites or 
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their functions.  To study the induction and function of secondary metabolites we 
decided to investigate their roles through bacterial interactions.  By co-culturing in an 
artificial setting we can observe perturbations in a defined system, allowing us to suggest 
and test hypotheses.   
This work shows two instances of streptomycetes exhibiting features of 
adaptations to their surroundings which may have arisen from bacterial competition.  
Streptomyces sp. Mg1 was determined to be resistant to surfactin, a molecule produced 
by Bacillus subtilis which inhibits aerial hyphae development.  The other story is of a 
streptomycete adapting to its neighbors is of S. coelicolor, which in the presence of some 
strains of B. subtilis is able to produce undecylprodigiosin, a molecule with antibiotic 
properties, earlier than it normally would. 
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CHAPTER II  
 
ENZYMATIC RESISTANCE TO THE SECRETED LIPOPEPTIDE SURFACTIN1 
 
2.1 Introduction 
2.1.1 Observation of surfactin hydrolysis 
From a separate matrix associated laser desorption ionization imaging mass 
spectrometry (MALDI-IMS) project studying the effects of a molecule produced by 
Streptomyces sp. Mg1 (S. Mg1 or Mg1) against Bacillus subtilis, there was an unrelated 
observation of a distinct pattern around S. Mg1 (Figure 2.1).  The top panel in Figure 
2.1A is a representative mass spectrum proximal to B. subtilis, with the 1058 m/z peak 
represented in cyan in 2.1B, the m/z is equivalent to an isoform of surfactin plus a 
sodium ion.  The bottom panel in Figure 2.1A is a representative mass spectrum from the 
area proximal to S. Mg1, with the 1076 m/z peak represented in fuchsia in 2.1B.  The 
+18 m/z mass was an unidentified molecule, but was a possible indication of surfactin 
hydrolysis.  When looking at the dataset, it was observed that the signal for surfactin was 
more intense by B. subtilis, but the signal decreased in proximity to S. Mg1 while the 
+18 m/z signal gained intensity near S. Mg1.  When looking at the IMS data, signals for 
                                                 
1Portions of this chapter have been reprinted with permission from ‘Enzymatic resistance 
to the lipopeptide surfactin as identified through imaging mass spectrometry of bacterial 
competition’ Hoefler BC, Gorzelnik KV, Yang JY, Hendricks N, Dorrestein PC & 
Straight PD Proc Natl Acad Sci U S A 109: 13082-13087, 2012. Reproduction or use of 
this material is subject to the copyright policy for PNAS:  
http://www.pnas.org/site/aboutpnas/rightperm.xhtml. 
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surfactin away from S. Mg1 were still intact, even if they were an equal distance from B. 
subtilis.  Surfactin has multiple isoforms and for each isoform there was a +18 m/z signal 
near S. Mg1, but not away from S. Mg1, leading us to the conclusion that Mg1 was 
probably degrading surfactin through hydrolysis.  The goal of this research was to 
identify a mechanism of degradation of surfactin by S. Mg1. 
 
 
Figure 2.1.  Surfactin hydrolysis is proximal to S. Mg1.  A) Representative mass spectra from the MALDI-
IMS experiment, while B) top panel is an image of the co-culture experiment and the bottom panels are 
false color visualizations of the 1058 m/z peak (cyan) and the 1076 m/z peak (fuchsia).  Work done by 
Chris Hoefler while visiting the Dorrestein lab, University of California, San Diego. 
 
 
2.1.2 Background on surfactin 
Surfactin is a produced by a number of Bacillus species other than B. subtilis, 
including, but not limited to: B. amyloliquefaciens (Arguelles-Arias, et al., 2009), B. 
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thuringiensis (Abderrahmani, et al., 2011), B. licheniformis (Thaniyavarn, et al., 2003), 
B. mojavensis (Snook, et al., 2009), B. natto (Kameda, et al., 1974), and B. pumilus 
(Morikawa, et al., 1992).  Surfactin was discovered in 1968, named surfactin for its 
‘strong surface active nature’ (as a surfactant) and initially characterized as an inhibitor 
of fibrin clot formation (hemolytic in nature) (Arima, et al., 1968, Bernheim.Aw & 
Avigad, 1970).  The structure of surfactin was described the following year, (Figure 2.2) 
which classified it as a cyclic lipodepsipeptide (Kakinuma, et al., 1969).   
 
 
 
Figure 2.2.  Structure of surfactin.  Note the variable length acyl chain, there are typically 9-11 
‘n’ -CH2 groups in the acyl chain.  Yellow box highlights the ester which is a possible site of hydrolysis. 
 
 
2.1.3 Chemical properties of surfactin 
Surfactin is an amphiphilic molecule with a non-polar acyl tail varying in length 
by the addition of -CH2 groups in its tail and it has a peptide head group containing 
seven amino acids cyclized by a lactone (Kakinuma, et al., 1969).  The cyclized peptide 
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moiety of surfactin is composed of D- and L-amino acids, allowing it to fold into a more 
compact, ‘horse saddle’ structure which contributes to the stability of the molecule and 
its ‘powerful biosurfactant’ properties (Magetdana & Ptak, 1992, Thimon, et al., 1992).  
The critical micelle concentration has been found to be as low as 7.5µM in Tris·HCl 
(Ishigami, et al., 1995).  Surfactin’s micelle forming properties enable surfactin to insert 
itself into membranes, and in some cases, has been proposed to form pores (Sheppard, et 
al., 1991, Lopez, et al., 2009). 
 
2.1.4 Applications of surfactin 
Surfactin has been described as having anti-foaming activities due to its 
amphiphilic properties (Razafindralambo, et al., 1998), anti-cancer properties (Kameda, 
et al., 1974, Seydlova & Svobodova, 2008), anti-mycoplasmic properties (Béven & 
Wróblewski, 1997), as well as antiviral properties (Kracht, et al., 1999).  While these 
properties allow us to classify it as a useful molecule, B. subtilis produces it for a variety 
of reasons: as an antibiotic (Ongena & Jacques, 2008), as a signal for biofilm formation 
by causing potassium leakage after puncturing membranes (Lopez, et al., 2009), B. 
subtilis also uses surfactin to lower surface tension allowing it to swarm outward 
(Kearns & Losick, 2003, Angelini, et al., 2009).  The lowering of surface tension has led 
to surfactin being proposed to be an environmentally friendly way enhance oil recovery 
compared to artificial compounds (McInerney, et al., 1990), yet this remains elusive due 
to the high price of commercially available surfactin (Peypoux, et al., 1999). 
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2.1.5 Surfactin is an antagonistic agent produced by B. subtilis against competitors 
Importantly, for this work, surfactin acts as an antagonistic agent against other 
soil organisms (Straight, et al., 2006).  When co-culturing B. subtilis against S. 
coelicolor there was an inhibition of aerial hyphae development within S. coelicolor.  A 
transposon screen of B. subtilis revealed one mutant which no longer inhibited aerial 
growth in S. coelicolor, an insertion into the srfAB genes (Straight, et al., 2006), the first 
two genes of the operon responsible for surfactin production (Peypoux, et al., 1999).  
Upon a deletion of the first gene in the operon, srfAA, the phenotype was the same, no 
inhibition of aerial hyphae development, where there previously was inhibition with 
wild-type B. subtilis (Straight, et al., 2006).  Application of purified surfactin 
exogenously to S. coelicolor inhibited aerial hyphae development, further confirming 
that surfactin was responsible for the phenotype exhibited within S. coelicolor  (Straight, 
et al., 2006).  Upon further testing, amongst other streptomycetes, it was found that other 
streptomycetes were also sensitive to the inhibition of aerial development by surfactin 
(Straight, et al., 2006). 
 
2.1.6 Resistance mechanisms to surfactin have not been identified 
Surfactin, being produced by a wide amount of organisms, presumably is 
degraded by neighboring organisms.  There is one report of surfactin, in a mixture of 
biosurfactants, possibly being degraded by other bacteria (Lima, et al., 2011), however 
the degradation was implied due to an increase in surface tension, not analytically 
measuring the compound.  Turnover of secondary metabolites in the environment is 
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common, often beneficial in a clinical mindset, whereby there is limited selective 
pressure to develop resistance to the molecule (D'Costa, et al., 2012), as is the case with 
clinically relevant antibiotics (Demain & Sanchez, 2009).  Surfactin hydrolysis has been 
observed before, albeit in an artificial setting, where surfactin was degraded by a 
commercially available protease, V8 endoprotease from Staphylococcus aureus 
(Grangemard, et al., 1999).  However, hydrolysis was limited to <15% over an extended 
time period (80µM enzyme for 100 hours), which the authors attributed to, ‘the 
aggregation state of the lipopeptide in solution’ or in other words: micelle formation 
(Grangemard, et al., 1999). 
 
2.1.7 Surfactin prevents aerial hyphae formation in streptomycetes 
Streptomycetes are often isolated with Bacillus spp., as they share a common 
niche in the soil.  Since all streptomycetes previously tested were no longer able to 
develop aerial hyphae, complete their lifecycle by forming spores, it was hypothesized 
that surfactin acts as a competitive agent by B. subtilis (Straight, et al., 2006).  With 
evidence of hydrolysis, as seen by the +18 m/z mass shift proximal to S. Mg1 (Figure 
2.1), we hypothesized there was an enzyme produced by S. Mg1 capable of degrading 
surfactin, and thus acting as a resistance mechanism by S. Mg1.  To see how widespread 
this phenomenon was our lab tested purified surfactin against a new set of 
streptomycetes and determined that hydrolysis of surfactin by S. Mg1 was a unique 
phenomenon (Figure 2.3). 
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Figure 2.3.  Purified surfactin inhibits spore formation in a number of streptomycetes.  The top panels have 
5µL of DMSO applied to them, while the bottom panels are the same organisms but with 100µg of 
surfactin dissolved in DMSO applied to them.  Note: there is killing by surfactin in some of the organisms, 
but Mg1 is resistant to inhibition of aerial hyphae development seen in the other streptomycetes.  Work 
done by Chris Hoefler. 
 
 
2.1.8 Initial search for a surfactin degrading enzyme 
In order to determine if a secreted enzyme was responsible for surfactin 
hydrolysis several plates of S. Mg1 had the bacterial colonies removed and the agar 
extracted for secreted proteins.  Mass spectrometry was carried out after a trypsin digest 
of the secreted proteins was subjected to mass spectrometry and a list of possible 
candidates was determined, prior to the start of this project (Table 2.1 for a list of 
possible candidates).  These secreted proteins formed the initial candidates for a 
surfactin degrading enzyme. 
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Table 2.1:  Secreted proteins of Streptomyces sp. Mg1, identified through a trypsin digest followed by 
tandem LC/MS/MS.  Identified proteins are listed by their putative BLAST annotations, with gi accession 
numbers of the proteins from S. Mg1, and probable molecular weight. Work done by Chris Hoefler and 
Larry Dangott. 
Identified Proteins 
Accession 
Number 
Molecular 
Weight 
beta glucosidase gi|254385125 88 kDa 
hypothetical protein gi|254383925 87 kDa 
Trypsinogen gi|254387105 27 kDa 
secreted protein gi|254385995 76 kDa 
extracellular solute-binding protein gi|254386889 45 kDa 
peptidase S8 and S53 subtilisin kexin sedolisin gi|254381890 51 kDa 
serine protease gi|254382793 115 kDa 
conserved hypothetical protein gi|254386403 53 kDa 
leupeptin-inactivating enzyme gi|254382420 45 kDa 
twin-arginine translocation pathway signal gi|254383653 54 kDa 
streptogrisin-B gi|254387168 30 kDa 
sugar hydrolase gi|254380558 42 kDa 
conserved hypothetical protein gi|297204780 54 kDa 
phospholipase D gi|21912970 58 kDa 
conserved hypothetical protein gi|254385470 29 kDa 
ABC transporter solute-binding protein gi|254386063 38 kDa 
ferrichrome ABC transporter substrate-binding protein gi|254384716 37 kDa 
phospholipase D gi|254384004 36 kDa 
secreted tripeptidylaminopeptidase gi|254384290 58 kDa 
secreted hydrolase gi|254386602 54 kDa 
hypothetical protein gi|254380900 28 kDa 
large secreted protein gi|254384157 64 kDa 
tellurium resistance protein gi|254382842 20 kDa 
branched chain amino acid binding protein gi|254384241 42 kDa 
aconitate hydratase gi|254386056 97 kDa 
glycine betaine ABC transport system permease gi|254387391 64 kDa 
glutamate binding periplasmic protein gi|254386082 30 kDa 
gamma-glutamyltranspeptidase gi|254382220 62 kDa 
Phytase gi|254381873 59 kDa 
peptidyl-prolyl cis-trans isomerase gi|254380548 27 kDa 
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2.2 Materials and Methods 
2.2.1 Bacterial strains 
The strains used in this chapter are listed in Table 2.2.  For long term storage 
Escherichia coli strains were grown overnight, spun down, and resuspended in sterile 
20% (v/v) glycerol, and stored at -80°C.  For streptomycetes the spore suspensions were 
prepared in sterile mqH2O then stored at -80°C.  Spore suspensions of Streptomyces sp. 
Mg1 were prepared using previously established protocols (Kieser, et al., 2000).  
Briefly, a -80°C stock of the streptomycete was struck out in a square-like pattern onto a 
GYM plate (see recipe below), once spore formation occurred (~3-4 days) 1mL of sterile 
mqH2O was applied to the plate and spores were scraped with a cell scraper, removed 
and 1mL more of sterile mqH2O was applied and taken off with a pipette.  The spores 
were serially diluted in sterile mqH2O and plated on GYM plates to get a working titer 
for experiments. 
 
 
Table 2.2.  Bacterial strains used in this chapter. 
Strain Relevant Genotype 
PDS0066 Bacillus subtilis NCIB3610 wild type 
PDS0060 Bacillus subtilis ΔsrfAA 
PSK0558 Streptomyces sp. Mg1 wild type 
PDS0366 Streptomyces sp. Mg1 ΔsfhA 
PDS0424 Streptomyces sp. Mg1 ΔsfhA sfhA ApR 
PSK0028 Streptomyces coelicolor M145 
PSK0495 Streptomyces canus 
 XL10-Gold (Cloning cell line from Stratagene) 
 BL21(DE3)pLysS (Escherichia coli for protein expression) 
 Rosetta™ 2(DE3)pLysS Novagen (E. coli for protein expression) 
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2.2.2 Media 
Bacto media was used, unless otherwise noted.  Luria-Bertoni (LB) broth (1% 
w/v tryptone, 0.5% w/v yeast extract, and 0.5% w/v NaCl) was used for Escherichia coli 
and Bacillus subtilis cultures, with LB plates having 1.5% agar added.  LB was 
supplemented with 100µg/mL ampicillin, 25µg/mL kanamycin or 30µg/mL 
chloramphenicol as appropriate for E. coli. All antibiotics used were purchased from 
Sigma.  Streptomyces spp. cultures were grown on glucose-yeast-malt extract (GYM) 
(1% w/v malt extract, 0.4% w/v yeast extract, 0.4% w/v dextrose) with GYM plates 
having 1.5% agar added.  Streptomyces coelicolor was cultivated on malt extract-yeast 
extract-mannitol (MYM) plates (0.4% w/v malt extract, 0.4% w/v yeast extract, 0.4% D-
(+)-maltose monohydrate (MP Biomedicals) with 1.5% agar. 
 
2.2.3 Cloning possible hydrolases 
Cloning was done using a ligation-free cloning technique to place possible 
hydrolase genes into a pET28a vector for overexpression in Escherichia coli.  The 
possible hydrolase ORFs were amplified from Streptomyces Mg1 genomic DNA by 
using primers listed in Table 2, using standard techniques [1x Phusion GC buffer, 10% 
DMSO, 0.2mM dNTPs (New England Biolabs), 0.2µM of each primer, 200-400ng 
genomic DNA, 1 unit of Phusion polymerase (New England Biolabs), all in a 50µL 
reaction], for the following 5-step program: (1) 98°C for 30 seconds, (2) 98°C for 10 
seconds, (3) variable annealing temperature for 30°C, (4) 72°C for 20 seconds, steps 2-4 
were repeated for 30 cycles before step (5) 72°C for 2 minutes.  The amplified product 
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was cleaned up using a QIAquick PCR purification kit as per the manufacturer’s 
instructions, and amplified for a second time with primers to extend the overhang 
regions 40bp further, matching the region around the EcoRI cut site in the pET28a 
expression vector.  The elongated product was gel purified using a QIAquick gel 
extraction kit as per the manufacturer’s instructions, and used as a ‘mega primer’ for 
amplification of an EcoRI cut pET28a.  pET28a was purified using a QIAprep spin 
miniprep kit, as per the manufacturer’s recommendations, from an overnight culture of 
E. coli XL10-Gold cells with the empty vector.  pET28a was cut with 60 units of EcoRI 
(3µL of 20,000 units/mL) and 1µg of pET28a, in 1x NEB Buffer EcoRI, in a 50µL 
reaction for 1 hour, then cleaned up using a QIAquick PCR purification kit.  The 
amplification of the cut pET28a was done with ~200ng of the ‘mega primer’ PCR 
product, ~100ng of cut pET28a, 2mM dNTPs, and 1 unit of Phusion polymerase for the 
following program: (1) 98°C for 30 seconds, (2) 98°C for 10 seconds, (3) 72°C for 30 
seconds, (4) 72°C for 2 minutes, steps 2-4 were repeated 24 times before step (5) 72°C 
for 2 minutes.  Five microliters of the reaction were transformed without cleaning up 
into chemically competent XL-10 Gold cells, using standard chemical transformation 
procedures.  Transformations involved letting the newly amplified plasmid mix with 
chemically competent cells for five minutes on ice, heat shocking at 42°C for 45 
seconds, then placing on ice for 1-2 minutes, adding 1mL of LB into the microcentrifuge 
tube, and allowing the cells to recover at 37°C, shaking at ~200rpm, for 1 hour, then 
plating on LB plates with appropriate antibiotics.  Clones were verified for the correct 
insert using their initial primers, restriction digests, and finally sequencing.  Upon 
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verification of the correct insert the plasmids were transformed into E. coli expression 
strains: either BL21(DE3)pLysS or Rosetta2(DE3)pLysS.  
 
 
Table 2.3.  Primers used in this study.  Capital letters indicated the overhang for ligation independent 
cloning. 
 
 
 
2.2.4 Expression of possible hydrolases 
A starter culture of the expression strain (either BL21(DE3)pLysS or 
Rosetta2(DE3)pLysS) was inoculated from a fresh plate and incubated at ~200rpm 
overnight at 37 °C. The starter culture was diluted into a larger culture such that the 
OD600 = ~0.005 (typically a 1:1000 dilution), and the large culture was incubated at 
250rpm until OD600 = 0.4 – 0.6 was reached. The temperature was then lowered to 16 °C 
for 1 h, followed by the addition of IPTG to a final concentration of 200µM, which was 
determined to be the least amount needed for soluble expression in 
Rosetta2(DE3)pLysS. Incubation was continued at 16 °C for 4 h. The cells were pelleted 
 18 
 
by centrifugation (8,000 × g for 30 minutes at 4°C).  The cell pellet was resuspended in 
lysis buffer (10mM imidazole, and 100mM sodium phosphate at pH 8.0), and lysed by 
sonication (Misonix Sonicator 3000) on ice at power 0.5 for small cultures for 10 
seconds on, 15 seconds off for 2 minutes total running time.  The lysate was centrifuged 
(13,000 × g for 30 minutes at 4°C), the pellet was saved to run on a gel, and the 
supernatant saved for further assays and running on a gel.   
 
2.2.5 SDS-PAGE 
Denaturing sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) was used according to standard methods in 12% acrylamide gels.  Samples were 
denatured by heating at 100°C for 5-10 minutes in 1x Laemmli buffer (62.5mM Tris-
HCl at pH 6.8, 1.5% w/v SDS, 100mM DTT, 0.005% bromophenol blue, and 8.3% v/v 
glycerol).  For urea-containing samples (below), Laemmli buffer was added, and 
samples were loaded directly into the gel without heating.  Electrophoresis was carried 
out between 100-200V, as time necessitated.  Protein bands were visualized by staining 
with colloidal Coomassie (Dyballa & Metzger, 2009), which calls for 20% v/v ethanol, 
10% w/v (NH4)2SO3, 2% w/v H3PO4, and 0.1% Coomassie Brilliant Blue G-250, first 
having the aluminum sulfate dissolved in mqH2O, ethanol added in, mixed with 
coomassie blue, phosphoric acid added in, then brought up to final volume in mqH2O. 
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2.2.6 Preliminary surfactin hydrolysis assay 
To identify the possible surfactin hydrolase, supernatants with soluble protein 
had surfactin added to them at a concentration of 200µM, and were allowed to incubate 
for three hours at room temperature.  Afterward 50µL was removed and mixed with five 
volumes of acetone to precipitate protein.  Precipitated protein was pelleted (13,000 x g, 
for 5 minutes at room temperature) and the supernatant removed to another tube.  1µL of 
the supernatant was spotted onto a MALDI plate then mixed with 1µL of a saturated 
solution of Universal MALDI Matrix (Sigma) which was dissolved in a 1:1 mixture of 
acetonitrile:water with 0.2% TFA added in.  The sample/matrix solution was allowed to 
dry, and MS spectra were collected on a Shimadzu Axima-CFR MALDI-TOF mass 
spectrometer.  The extent of surfactin hydrolysis was determined (semi-quantitatively) 
by comparing the ratios of intact surfactin ions ([Mass+Na]+) from a control sample to 
hydrolyzed surfactin in the samples ([M+Na+H2O]
+) at different time points. 
 
2.2.7 Optimization of expression conditions and purification of surfactin hydrolase 
 After expression tests in BL21(DE3)pLysS yielded almost no detectable soluble 
product (as determined by SDS-PAGE) the pET28a plasmids with various inserts were 
transformed into Rosetta2(DE3)pLysS competent cells, as described above.  Induction of 
possible hydrolases was tried for varying lengths of induction (1 hour to overnight), 
varying temperatures (16°C, 25°C, 30°C, and 37°C), and varying concentrations of 
inducer (0.1mM IPTG – 2mM IPTG).  Induction conditions were optimized to levels of 
highest expression upon lysing the cells: once OD600 = ~0.5, lowering the temperature 
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from 37°C to 16°C, letting the cells adjust for ~1 hour, inducing with 0.2mM IPTG, then 
letting the cells grow for ~4 hours before harvesting.  However, much of the protein was 
insoluble.  In order to bypass the solubility problem of the candidate hydrolase, insoluble 
protein was unfolded, purified under denaturing conditions, and refolded.  After 
expression of the protein the cell pellet was resuspended under denaturing conditions 
(denaturing lysis buffer: 8M urea, 10mM imidazole, and 100mM sodium phosphate at 
pH 8.0, made with fresh urea each time), lysed by sonication on ice (for large 
preparations: power 4 for 10 seconds on, 15 seconds off for 10 minutes total running 
time), spun down as described above, the pellet discarded, the supernatant run over a 
hand-poured Ni+-NTA Superflow (Qiagen) column (10 mL of bed volume, washed with 
2 CV water and equilibrated with 3 CV lysis buffer).  The column was washed (8 M 
urea, 10 mM imidazole, and 100 mM sodium phosphate at pH 6.3; 3 CV) and then 
eluted (8 M urea, 10 mM imidazole, and 100 mM sodium phosphate at pH 5.9; 3 CV, 
followed by 3 CV of the same buffer at pH 4.5). Fractions (2 mL) were collected and 
screened for total protein by using Bradford’s reagent (Sigma).  Protein containing 
fractions were further screened by SDS-PAGE, and secreted hydrolase (54-kDa band) 
containing fractions were pooled.  The overexpressed protein was gradually refolded by 
dialysis of the urea in steps. A starting dialysis buffer (7 M urea, 500 mM NaCl, 10 mM 
imidazole, and 50 mM sodium phosphate at pH 7.5) was prepared (1.5 L), and dialysis 
was carried out for 3-4 hours, then the dialysis bag was placed in a new container with 
6M urea (all the other components the same), the process repeated with 1M urea steps 
down, until all the urea was removed.  At the 1M urea step 1mM DTT was added into 
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the dialysis buffer.  As some protein precipitated the final product was spun down, as 
described previously. The supernatant was applied to a second Ni+-NTA column for 
further purification, after the column was equilibrated with binding buffer (50mM 
sodium phosphate at pH 7.5, 500mM NaCl, and 10mM imidazole; 3 CV). The column 
was washed (50mM sodium phosphate at pH 7.5, 500mM NaCl, and 80mM imidazole; 3 
CV) and then eluted (50mM sodium phosphate at pH 7.5, 500mM NaCl, and 120mM 
imidazole for 3 CV, followed by 3 CV of the same buffer with 150mM imidazole). 
Fractions (2 mL) were collected and screened as before. Secreted hydrolase containing 
fractions were pooled and dialyzed into the final storage buffer (50mM Tris·HCl at pH 
8.0, 150mM NaCl, 1mM DTT, and 10% glycerol). The purified protein was stored as an 
80µg/mL stock at 4 °C for use in subsequent experiments. 
 
2.2.8 Extraction of metabolites from B. subtilis and various streptomycetes for 
enzymatic assays 
Extraction of surfactin was done from wild-type B. subtilis NCIB3610 
(PDS0066) as follows: a starter culture was inoculated from a 1 day old plate of B. 
subtilis, after overnight growth the starter culture was used to inoculate a larger culture 
in LB to OD600 = 0.01, the large culture was grown for ~20 hours, cells pelleted by 
centrifugation at 8,000 x g, for 30 minutes at 4°C.  The pellet was discarded and the 
supernatant was extracted with 1 volume (equivalent to supernatant volume) of 1:2:3 
methanol:methylene chloride:ethyl acetate, with the organic layer saved and the aqueous 
layer further extracted with 1 volume of butanol.  The organic fractions were 
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concentrated under reduced pressure, resuspended in methanol, and adsorbed onto 
Diaion HP-20 resin (Sigma) under reduced pressure.  The resin was transferred to a 
Büchner funnel, washed with water, then 20% methanol/water, v/v.  Surfactin was eluted 
with 100% methanol followed by 100% water, then both eluates were dried under 
pressure and combined.  Extraction of plipastatin was done from a B. subtilis ΔsrfAA 
background (PDS0060) to eliminate surfactin background production, and thus 
competition for precursor molecules.  Extraction was performed in the same way as for 
surfactin.  Extraction of CDA, calcium-dependent antibiotic, from S. coelicolor M145 
was done on MYM plates supplemented with trace elements (0.08mg/L ZnCl2, 0.4mg/L 
FeCl3·6H2O, 0.02 mg/L CuCl2·2H2O, 0.02mg/L MnCl2·4H2O, 0.02 Na2B4O7·10H2O, 
0.02 mg/L (NH4)6Mo7O24·4H2O, 2 mM MgCl2, 0.7 mM CaCl2, 2µM thiamine·HCl, 
50µg/mL phenylalanine, and 50µg/mL tryptophan) after autoclaving and cooling down 
to 50°C.  After adding spores the plates were allowed to incubate until aerial hyphae 
were observed. The agar was cut into ~1cm pieces, and extracted as surfactin, except 
that the organic layer was poured off of the agar pieces instead of using a separatory 
funnel.  Amphomycin was extracted from 3-day old cultures of S. canus (PSK0495) 
following a similar procedure surfactin, except the culture was grown in MYM broth, 
inoculated with 106 spores/mL. 
 
2.2.9 Enzymatic assays with purified surfactin hydrolase 
Surfactin was titrated from 10µM to 1mM into a 100µL final reaction volume 
(50mM Tris·HCl, 150mM NaCl, 1mM freshly added DTT, all at pH 8.0) with ~60nM of 
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the enzyme (320ng surfactin hydrolase).  The assays were allowed to run for 1 hour at 
room temperature (20-23°C), before being quenched with five volumes of acetone 
(500µL).  The optimal concentration to get cleavage of surfactin at a high enough 
intensity compared to the background using MALDI-TOF was found to be 50µM 
surfactin.  1µL of the quenched reaction was spotted onto a MALDI plate then mixed 
with 1µL of a saturated matrix solution as described above.  The sample/matrix solution 
was allowed to dry then MS spectra were collected on a Shimadzu Axima-CFR MALDI-
TOF mass spectrometer.  The extent of surfactin hydrolysis was determined (semi-
quantitatively) by comparing the ratios of intact surfactin ions ([Mass+Na]+) from a 
control sample to hydrolyzed surfactin in the samples ([M+Na+H2O]
+) at different time 
points.  Enzymatic assays with purified compounds (daptomycin, nystatin, iturin a, 
amphotericin b, erythromycin, and A5145D) were done at 50µM compound, with the 
other conditions kept the same.  Enzymatic assays with crude extracts (surfactin, 
plipastatin, amphomycin, and CDA) were done in a similar fashion, except the substrates 
were assayed at several concentrations to get the best signal to noise ratio.  After testing 
CDA, all of the substrates were retested with varying concentrations of Ca2+, from 0mM 
– 10mM, all other conditions remaining the same.  KCl and phosphate buffer 
(K2HPO4/KH2PO4 at 50mM, pH 8.0) were also tried but were not found to affect the 
hydrolysis. 
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2.2.10 Preparation of hydrolyzed surfactin for NMR 
Enzymatically hydrolyzed surfactin and a surfactin control were prepared for 
NMR in the following way with everything the same between the two samples, except 
for the surfactin control the enzyme was heat denatured by boiling at 100°C for 20 
minutes prior to preparation.  The samples were prepared by incubating 3mg of surfactin 
(~500µM surfactin) with 30nM of surfactin hydrolase (10µg enzyme) in 6mL assay 
buffer (50mM Tris·HCl, 150mM NaCl, 1mM freshly added DTT, all at pH 8.0) for an 
overnight incubation with shaking.  Surfactin and hydrolyzed surfactin from each sample 
were isolated by adsorbing the mixture to a pre-wetted Merck LiChrolut RP-18e SPE 
cartridge (pre-wetted by running 3mL of methanol then 3mL of 20% methanol/water 
v/v, then 6mL of water), then washed with 6mL of water, 3mL of 10% methanol/water 
v/v, 3mL of 20% methanol/water v/v, the surfactin and hydrolyzed surfactin from each 
sample were eluted with ~10mL of methanol, concentrated to dryness under reduced 
pressure, then dissolved in 600µL of deuterated DMSO-d6.  NMR was done by 
Xiangming Kong in the Biomolecular NMR Laboratory at Texas A&M University, and 
analyzed for location of hydrolysis by Chris Hoefler, comparing to previously solved 
structures of intact surfactin (Tang, et al., 2007). 
 
2.2.11 Small scale preparation of Streptomyces gDNA to confirm genetic 
manipulations 
To confirm the deletion of srfA and its chromosomal complementation small 
scale (5-10mL) preparations were done of many isolates from each step.   Picked an 
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isolated colony, ground the mycelia using a sterilized tissue grinder or toothpick, 
inoculated a 5-10mL culture of the required media (MYM, see above).  Grew cells 
overnight at 30°C in a roller drum at ~200rpm (the longer the growth the thicker the cell 
wall, making it harder to lyse the cells and get clean DNA). Spun down cells, 8,000 x g 
for 5 minutes at room temperature.  Washed cells with 1mL genomic lysis buffer (50mM 
EDTA, 0.1M NaCl, pH 7.5), spun down as above and resuspended in 700µL of lysis 
buffer, with added in lysozyme and ProteinaseK.  Lysozyme was weighed out fresh, to 
prevent degradation, and added at 5-50mg/mL depending on the difficulty of lysing cells 
(for S. Mg1 10mg/mL was used).  ProteinaseK was stored at -20°C in a 20mg/mL stock, 
20µL were added to a small scale preparation.  Incubated at 37°C for >20 minutes, 
inverting periodically.  After addition of lysozyme and ProteinaseK the solutions were 
never vortexed, to prevent shearing of gDNA.  The solution turns clear and somewhat 
viscous, incubations of two hours worked fine.  Added 20µL of RNaseA (20mg/mL), 
incubated at 37°C for 10 minutes, inverting periodically.  Added 56µL of sarkosyl (20% 
w/vol sodium lauroyl sarcosinate in mqH2O), incubated 10 minutes at 37°C, the lysate 
becomes more clear and very viscous.  Extracted DNA using an equal volume of 
phenol/chloroform/isoamyl alcohol (25:24:1), by adding the solvents to the lysate and 
inverting periodically for 1 minute.  Transferred mixture to 2mL Eppendorf phase lock 
tubes and spun down for 5-10 minutes at max speed of bench top microcentrifuge.  The 
silica resin in these tubes separates the organic layer (on bottom) from the aqueous layer 
(on top, above the silica resin).  Transferred the aqueous layer to a new phase lock tube 
and extracted again as above.  Transferred the aqueous layer from the second extraction 
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to a microcentrifuge tube and added 5M NaCl to a final concentration of 0.8M 
(~110µL).  Added pre-heated CTAB to 0.1 volumes (~110µL).  CTAB, 
cetyltrimethylammonium bromide, solutions were 10% w/v in mqH2O with 0.7M NaCl.  
The mixtures were incubated at 65°C for 10 minutes and inverted periodically.  The 
mixtures were cooled down and extracted with an equal volume of chloroform/isoamyl 
alcohol, 24:1, in a regular microcentrifuge tube.  Spun down for 5 minutes at max speed, 
removed aqueous layer to as not to disturb the interface between the aqueous and 
organic layer which contained a white layer of proteins or polysaccharides.  Repeated 
the CTAB extraction as above, but had to add more CTAB than previously (to maintain 
the 0.1 volume ratio).  After the chloroform/isoamyl alcohol extraction the aqueous layer 
was diluted to ~0.48M NaCl with sterile mqH2O, as the phase lock tubes do not separate 
out organic from solvent with salt concentrations over 0.5M.  Phenol/ chloroform/ 
isoamyl alcohol extracted with phase lock tubes as described above.  Precipitated DNA 
from the aqueous layer with 0.7 volumes of isopropanol, removed DNA either by 
inverting tube gently and swirling a pipet tip in the solution and removing, or by 
centrifuging and decanting the supernatant.  In either case the DNA was dried then 
resuspended in 200µL TE buffer (10mM Tris·HCl, 1mM EDTA, pH 8.0).  Measured 
OD230, OD260, and OD280 and ran an aliquot on a gel to test integrity.  
 
2.2.12 Testing surfactin hydrolysis by S. Mg1 and derivatives in liquid culture 
In order to ensure that the surfactin hydrolase gene, newly termed sfhA, was the 
only gene responsible for surfactin hydrolysis the gene was knocked out and then 
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complemented with the wild-type gene.  To detect evidence of hydrolysis, or the lack 
thereof, S. Mg1 and its two derivatives, S. Mg1 ΔsfhA and S. Mg1 ΔsfhA sfhA ApR, each 
had 106 spores/mL inoculated into a 5mL liquid culture and were grown for 24 hours 
growing at 30°C and in a roller drum at ~200rpm, when 50µM surfactin was added to 
each culture.  The cultures were allowed to grow for another 24 hours before cells were 
pelleted by centrifugation (8,000 x g, for 10min at 25°C).  Supernatants from each 
sample were adsorbed onto a pre-wetted Merck LiChrolut RP-18e SPE cartridge (pre-
wetted by running 3mL of methanol then 3mL of 20% methanol/water v/v, then 6mL of 
water), then washed with 6mL of water, 3mL of 10% methanol/water v/v, 3mL of 20% 
methanol/water v/v, the surfactin and hydrolyzed surfactin from each sample were eluted 
with ~10mL of methanol, concentrated to dryness under reduced pressure, resuspended 
in 0.5mL.  Samples were analyzed via MALDI-TOF as described above. 
 
2.3 Results 
2.3.1 Selection, cloning and expression of candidate enzymes 
 Secreted proteins isolated from agar surrounding S. Mg1 colonies (listed in Table 
2.1) were analyzed for the possibility of being the degradative enzyme.  In order to 
narrow down the probable protein we first eliminated any proteins which were not 
enzymes, then focused on enzymes which were annotated as degradative in nature, such 
as proteases, peptidases, hydrolases, or lipases.  We further narrowed down the list by 
looking for proteins with homologues in streptomycetes which were not resistant to 
surfactin.  Five candidate S. Mg1 genes were chosen to be cloned into Escherichia coli 
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to be expressed: sugar hydrolase gi# 194339469, secreted protein gi# 194344857, 
secreted hydrolase gi# 194345445, large secreted protein gi# 194343046, and secreted 
aminopeptidase gi# 194343178.  These genes were chosen on the basis that their protein 
products were determined to be secreted, and were either annotated or had homologues 
that were annotated to be enzymatic and degradative.   
After cloning the candidate hydrolase genes into an overexpression vector with 
an N-terminal 6x-Histidine tag, the plasmids were transformed into BL21(DE3)pLysS 
cells.  After altering a number of variables used in protein expression, such as: 
alternating lengths of induction, temperature after induction, inducer molecule 
concentration, and optical density at time of induction, none of the constructs were able 
to express (data not shown).  We theorized this was due to the codon bias in E. coli, as 
streptomycetes have a GC rich genome (van Wezel & McDowall, 2011).  To overcome 
the codon bias, the pET28a plasmids with the various genes inserted into them were 
transformed into Rosetta2(DE3)pLysS chemically competent cells.   
 
2.3.2 Lysate activity assays of candidate enzymes 
Of the four proteins able to express, only two had enough soluble protein to 
detect via western blot or SDS-PAGE, under a variety of expression conditions tried 
(data not shown).  However, the two constructs, ‘secreted protein’ gi# 194344857 and 
the ‘secreted hydrolase’ gi# 194345445, were expressed on a small scale (100mL for 4 
hours), spun down, resuspended in 1mL of lysis buffer (see materials and methods), 
lysed, spun down, pellets removed, and had surfactin added at a concentration of 1mM 
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to the supernatant of the lysate.  After allowing surfactin to react with the supernatant for 
one hour at room temperature a 50µL aliquot was removed from each sample, mixed 
with 250µL acetone, insoluble material pelleted, and analyzed via MALDI-TOF.  There 
was no evident surfactin hydrolysis, however, after allowing the reactions to proceed 
overnight, and treating the reactions in the same manner as before, there was a faint 
amount of hydrolysis (Figure 2.4), albeit only in the linear detection mode of detection, 
not in reflectron mode which has more resolved peaks. 
 
 
 
Figure 2.4.  Fractionated crude lysates yield a possible hydrolase candidate.  Two soluble candidate 
proteins were lysed, fractionated, and surfactin added to the supernatants.  After 22 hours there was faint 
levels of hydrolysis in the ‘secreted hydrolase’ lysate (gi# 194345445).  Circled peak was not present in 
either the empty vector lysate or the other expressed gene. 
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2.3.3 Expression and refolding of ‘secreted hydrolase' 
 The faint level of hydrolysis was enough to pursue the protein annotated as 
‘secreted hydrolase.’  The low levels of hydrolysis were most likely due to only a faint 
amount of the protein being soluble.  Figure 2.5 is a representative gel of further 
purification of the ‘secreted hydrolase’, which shows that most of the expressed protein 
is insoluble (compare supernatant and pellet of expressed hydrolase S vs. P).  Low levels 
of hydrolysis could also be due to increased micelle formation at higher concentrations 
of surfactin, see below. 
 
 
 
Figure 2.5.  Purification of surfactin hydrolase.  The ‘secreted hydrolase’ is a 54kD protein which is 
overexpressed.  Lanes are marked +/- for ‘secreted hydrolase’ inserted into pET28a or if it was just the 
empty vector.  WL = whole cell lysate, S = supernatant, P = pellet, C1 = Ni2+-NTA column run under 
denaturing conditions, C2 = the refolded protein from C1 loaded onto a native Ni2+-NTA column, two 
groups of fractions from the elution step.   
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2.3.4 Identification of a surfactin degrading protein from S. Mg1 
After obtaining a relatively pure fraction of the ‘secreted hydrolase’ the enzyme 
was incubated with 50µM surfactin in a Tris·HCl assay buffer (see materials and 
methods) for a number of time points, the 10 minute time point is shown to illustrate 
how fast the surfactin was degraded with 60nM enzyme (Figure 2.6).  Assay buffer 
controls showed no detectable surfactin hydrolysis (data not shown).  The ‘secreted 
hydrolase’ is hence referred to as ‘surfactin hydrolase.’ 
 
 
Figure 2.6.  MALDI-TOF evidence of surfactin hydrolysis by ‘secreted hydrolase.’  50µM surfactin was 
incubated in a 100µL reaction (50mM Tris·HCl, 150mM NaCl, 1mM freshly added DTT, all at pH 8.0) 
with ~60nM surfactin hydrolase (320ng) for either 0 or 10 minutes at room temperature (20-23°C), before 
being quenched with five volumes of acetone (500µL).  The arrows indicate where the dominant peaks of 
each isoform were hydrolyzed (+18 m/z peak shifts).  
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2.3.5 Preparation of surfactin to determine site of hydrolysis 
In an effort to determine where the molecule was degraded by hydrolysis we 
hydrolyzed 3mg of surfactin and after cleanup over a C18 sep-pak cartridge determined 
it’s structure compared to a non-hydrolyzed control (molecule was mixed with denatured 
protein and treated the same way) and previously solved structures of various surfactin 
isoforms (Tang, et al., 2007).  The hydrolysis occurred at the ester bond within the 
lactone which cyclized the peptide backbone of surfactin, confirming tandem MS results 
from the MALDI-IMS (Hoefler, et al., 2012).   
 
2.3.6 Determining substrate specificity of surfactin hydrolase versus other B. subtilis 
compounds and daptomycin, another macrolactone 
From the initial MALDI-IMS experiments, which first identified surfactin 
hydrolysis, we had also noticed the same pattern for another molecule B. subtilis 
produced, plipastatin (Hoefler, et al., 2012).  We chose to pursue surfactin hydrolysis as 
surfactin blocks aerial hyphae development in streptomycetes (an observable 
phenotype), is much better studied, and, importantly, surfactin was commercially 
available.  Since plipastatin was also shown to be degraded in the MALDI-IMS 
experiments and is also a cyclic lipopeptide with a lactone cyclizing the backbone 
(Figure 2.7), it was hypothesized that the surfactin hydrolase enzyme identified above 
could also be the molecule degrading plipastatin.   
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Figure 2.7. Structures of Plipastatin, Iturin A, and Daptomycin.  Images adapted from the following 
sources: Plipastatin (Yang, et al., 2009); Iturin A (Moran, et al., 2009); Daptomycin (Clardy, et al., 2006).  
Plipastatin and Iturin A are produced by B. subtilis spp. while daptomycin is produced by a streptomycete, 
S. roseosporus.  Lactones are highlighted in yellow. 
 
 
Iturins are another class of compounds produced by B. subtilis (Romero, et al., 
2007).  Although iturin is not a cyclic lipopeptide with a lactone, it is a cyclic compound 
(Figure 2.7) produced by some B. subtilis strains.  As S. Mg1 was isolated with a B. 
subtilis strain, and there is evidence for activity against plipastatin, then it is feasible that 
the surfactin hydrolase has a broad specificity against B. subtilis compounds.  B. subtilis 
NCIB3610 (the strain used in the MALDI-IMS experiments) does not produce iturin, so 
there was no preliminary evidence to support this hypothesis.  To examine whether the 
enzyme was responsible for the observed plipastatin hydrolysis or could hydrolyze 
iturin, these molecules were tested against the surfactin hydrolase (Figure 2.8).  
Daptomycin, another lactone cyclized lipopeptide (Figure 2.7), which has ‘exceptional’ 
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therapeutic properties against gram-positive multi-drug resistant pathogens (D'Costa, et 
al., 2012), was also tested to see if there was substrate specificity against lactone 
cyclized lipopeptides (Figure 2.8). 
 
 
 
Figure 2.8.  MALDI-TOF spectra of the surfactin hydrolase tested against plipastatin, iturin a, and 
daptomycin.  Assay conditions are described in Materials and Methods, Iturin A (panel B), daptomycin 
(C) were tested at 50µM, while plipastatin (A) was extracted as described in Materials and Methods.  The 
top spectra in each sub-panel was substrate incubated with the hydrolase, while the bottom spectra in each 
panel was substrate incubated in buffer only.  There are only +18 m/z peak shifts (characteristic of 
hydrolysis) observed for plipastatin. 
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The surfactin hydrolase was able to degrade plipastatin as is seen through +18 
m/z peak shifts when incubated with the enzyme versus incubated without the enzyme 
(Figure 2.8A, top spectra vs. bottom spectra), there is a high level of noise due to the fact 
that an extract of B. subtilis was used, rather than the purified compound, as plipastatin 
is not commercially available.  The hydrolysis confirms the hypothesis that S. Mg1 is 
degrading plipastatin, as was proposed from the MALDI-IMS.  However, it cannot be 
ruled out that another enzyme from S. Mg1 could also act on plipastatin.  The enzyme 
was not able to degrade the other B. subtilis compound tested, iturin a (Figure 2.8B).  
While S. Mg1 may be resistant to iturin a in the soil, the surfactin and plipastatin 
degrading enzyme was unable to degrade it.  This led to the hypothesis that the surfactin 
hydrolase was specific to lactone cyclized lipopeptides.  However, the lack of 
daptomycin hydrolysis under conditions that saw surfactin and plipastatin rapidly 
degraded refuted this hypothesis (Figure 2.8C).  After extended incubations with a 
higher level of enzyme there was a faint amount of hydrolysis that was absent in buffer 
only controls and reproducible (Figure 2.9).  However, there was five times the 
concentration of enzyme (300µM as opposed to 60nM), incubations were two hours long 
(12 times the amount of time needed to completely hydrolyze a similar concentration of 
surfactin with 60nM enzyme) and hydrolysis was at best limited to 1-2% of the pool of 
daptomycin, so the evidence could be an artifact of adding an excess of the enzyme. 
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Figure 2.9.  MALDI-TOF spectra of an extended incubation of daptomycin with the surfactin hydrolase.  
Possible faint hydrolysis of daptomycin after a prolonged incubation with a higher concentration of the 
surfactin hydrolase.  The arrow indicates where hydrolyzed daptomycin might have been detected, as seen 
through a +18 m/z peak present from the dominant form of daptomycin. 
 
 
2.3.7 Determining substrate specificity against a variety of cyclic natural products 
To further determine the substrate specificity of the surfactin hydrolase a number 
of cyclized molecules were screened, which had a variety of scaffolds (Figure 2.10).  All 
the molecules tested were produced by soil organisms, so there is the possibility that S. 
Mg1 evolved the surfactin hydrolase to be active against them as well. 
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Figure 2.10.  Structures of various molecules tested against surfactin hydrolase.  A54145, A54145D is a 
derivative with side groups: R = anteiso-undecanoyl, R12 = Glu, R13 = Ile (Alexander, et al., 2010); 
Nystatin (Zotchev & Caffrey, 2009); Amphomycin where side groups: X = OH and R = Δ3-iso-
dodecenoyl (Baltz, et al., 2005); Amphotericin B (Zotchev & Caffrey, 2009); Erythromycin (von 
Nussbaum, et al., 2006); CDA, calcium dependent antibiotic, has multiple isoforms (Hojati, et al., 2002).  
Lactones are highlighted in yellow. 
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 A54145D, amphomycin, and CDA (calcium-dependent antibiotic) are all 
lipopeptides.  A54145D is a variant of A54145 which has a lactone cyclizing the peptide 
backbone and produced by S. fradiae (Counter, et al., 1990), amphomycin is produced 
by S. canus (Heinemann, et al., 1953), and CDA is a macrolactone produced by S. 
coelicolor (Hojati, et al., 2002).  Amphotericin b and nystatin are both macrolactone 
polyenes, with amphotericin b produced by S. nodosus (Caffrey, et al., 2001) and 
nystatin produced by S. noursei (Fjaervik & Zotchev, 2005).  Erythromycin is a 
macrolide produced by the actinomycete Saccharopolyspora erythraea (Donadio, et al., 
1991).  Conditions used to test the selected compounds were the same as for surfactin, 
with 60nM enzyme used against 50µM substrate in the Tris·HCl assay buffer (Figure 
2.11) with the exception of amphomycin and CDA, which were extracted as described in 
Materials and Methods. 
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Figure 2.11.  MALDI-TOF spectra of cyclic compounds tested against surfactin hydrolase.  Assay 
conditions are described in Materials and Methods.  The top spectrum in each panel is substrate incubated 
with the hydrolase, while the bottom spectrum in each panel is substrate incubated in buffer only.  A) 
A54145D, B) amphotericin b, C) nystatin, and D) erythromycin were at a concentration of 50µM, while E) 
amphomycin and F) CDA were extracted as described in Materials and Methods, and the lowest dilution 
which gave the best signal-to-noise ratio using MALDI-TOF was used. 
  
 40 
 
There was no hydrolysis of any molecules tested.  There are peaks arising in 
spectra from A54145D that differ between the enzyme treated sample and the buffer 
treated sample, but they were not +18 m/z, thus not hydrolysis, and after repeated tests 
these were shown to be non-reproducible artifacts (data not shown).  Surprisingly, the 
amphomycin and CDA extracts showed very little background while the commercially 
available amphotericin b and nystatin had a very high signal-to-noise ratio.  This is 
presumably due to the fact that amphotericin b and nystatin used were impure mixtures.   
 
2.3.8 Addition of CaCl2 to assay buffer in substrate specificity trials 
While there was no evidence of hydrolysis, this test led to a different set of 
experiments.  CDA, which is only active against gram-positive organisms in the 
presence of calcium (Lakey, et al., 1983), would presumably only act on S. Mg1 in the 
presence of calcium.  Calcium could either act on the molecule changing its 
conformation or aggregation properties, or calcium could cause a conformational change 
within the surfactin hydrolase, possibly opening up the active site to new substrates.  
Initially 10mM calcium was added to the assay buffer (Figure 2.12).   
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Figure 2.12.  MALDI-TOF spectra of CDA tested with or without CaCl2.  Assay conditions are described 
in Materials and Methods.  A) CDA tested with no CaCl2 added to the assay buffer and B) CDA tested 
with 10mM CaCl2 added to the assay buffer. The top spectrum in each panel is substrate incubated with 
the hydrolase, while the bottom spectrum in each panel was substrate incubated in buffer only.  CDA was 
extracted as described in Materials and Methods, and the lowest dilution which gave the best signal-to-
noise ratio using MALDI-TOF was used.   
 
 
As the CDA used was an extracted compound and an isolated purified molecule, 
there was a +18 m/z peak from the dominant 1517 m/z peaks.  The +18 m/z peak could 
have just been the molecule getting hydrolyzed during extraction, and was seen in 
samples with and without the enzyme.  There was no detectable change in level of 
hydrolysis of CDA with the addition of calcium.  As the surfactin hydrolase was just 
stored at 4°C, rather than being flash frozen and stored at -20°C or 80°C, with every new 
substrate, or set of assay conditions, the enzyme was tested against surfactin to see if it 
was still viable.  After testing surfactin with 10mM CaCl2 in the assay buffer and not 
seeing any activity, the enzyme was thought to be inactive, except it still hydrolyzed 
plipastatin (Figure 2.13).  Once it was determined that the enzyme was still active, and 
was just was no longer able to hydrolyze surfactin with calcium in the buffer, other 
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substrates were tested to see if their hydrolysis was affected.  Substrates which were not 
able to be hydrolyzed are not shown. 
 
 
 
Figure 2.13.  MALDI-TOF spectra of surfactin, plipastatin, and daptomycin +/- calcium in the assay 
buffer.  Assay conditions are described in Materials and Methods.  A), C), and E) show surfactin, 
plipastatin, and daptomycin reacted without added calcium in the assay buffer, respectively, while B), D), 
and F) show the same substrates with 10mM CaCl2 in the assay buffer.  The top spectrum in each panel is 
substrate incubated with the hydrolase, while the bottom spectrum in each panel was substrate incubated in 
buffer only.  Plipastatin was extracted as described in Materials and Methods, and the lowest dilution 
which gave the best signal-to-noise ratio using MALDI-TOF was used. 
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Surfactin hydrolysis was effectively eliminated by the addition of 10mM CaCl2, 
while control experiments without added CaCl2 showed that the enzyme was still active 
(data not shown).  However, plipastatin hydrolysis remained consistent with the addition 
of CaCl2.  Daptomycin was ~14% hydrolyzed, as calculated by adding the area of the 
1639 and 1640 m/z peaks divided by the total area of the 1621-1663 m/z peaks.  The 
assay conditions were the same as for surfactin (50µM substrate, 60nM enzyme, for 30 
minutes).  This was a remarkable shift from previous attempts to hydrolyze daptomycin 
with the enzyme, where a prolonged incubation with five times the amount of enzyme 
only yielded ~1-2% hydrolysis.  The increased daptomycin hydrolysis, coupled with the 
lack of surfactin hydrolysis, yields some interesting questions about the difference in 
critical micelle concentration of daptomycin versus surfactin in the presence of Ca2+.  No 
other previously unaffected substrates were able to be hydrolyzed (Table 2.4).  To 
investigate if altering the buffer composition would affect hydrolysis, the buffer was 
changed from Tris·HCl and NaCl to phosphate buffer and KCl but this did not affect the 
hydrolysis of any compounds (data not shown). 
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Table 2.4.  Surfactin hydrolase substrates are affected by the addition of CaCl2. 
 No added CaCl2 10mM CaCl2 
Surfactin +++ - 
Plipastatin +++ +++ 
Subtilosin - - 
Iturin A - - 
Daptomycin - + 
A54145D - - 
Nystatin - - 
Amphomycin - - 
Amphotericin B - - 
Erythromycin - - 
CDA - - 
+++ = >95% hydrolysis, + = partial hydrolysis (>10%), - = no detectable hydrolysis. 
 
 
2.3.9 Titration of calcium into the assay buffer to determine inhibition of surfactin 
hydrolysis 
The surprising role of calcium in the abolishment of surfactin hydrolysis led to 
the question of how much calcium does it take to eliminate surfactin hydrolysis.  
Calcium was added into the assay buffer at 0, 2.5mM, 5mM, 7.5mM, and 10mM to see 
whether the hydrolase would still hydrolyze surfactin with calcium present (Figure 2.14).  
This was done to determine if the concentration affecting the hydrolase was a 
qqphysiological concentration of calcium or a higher concentration less likely to be 
encountered by the enzyme in nature. 
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Figure 2.14.  MALDI-TOF spectra of surfactin hydrolysis assay with increasing amounts of calcium.  
Assay conditions are described in Materials and Methods.  After a 30 minute assay with the surfactin 
hydrolase enzyme, from bottom to top there is increasing amounts of CaCl2 added to the assay buffer, 
from no added CaCl2, to 2.5mM, 5mM, 7.5mM and 10mM CaCl2 in the top spectra.  The yellow box 
indicates where there would be the hydrolysis of the dominant 1044 m/z peak, while the blue box indicates 
where there would be hydrolysis of the next most abundant surfactin isoform, the 1058 m/z peak. 
 
 
2.3.10 Role of surfactin hydrolase in S. Mg1 resistance in vivo 
S. Mg1 was shown to degrade surfactin in vivo using MALDI-IMS (Figure 2.1) 
and a recombinant S. Mg1 protein was shown to hydrolyze surfactin in vitro (Figure 
2.6), but the hypothesis that the surfactin hydrolase was a resistance mechanism to 
surfactin mediated inhibition of aerial hyphae development in vivo cannot be addressed 
with these methods.  To determine whether the enzyme was the sole means of resistance 
to surfactin by S. Mg1 a knockout of its gene was made and then complemented back.  
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When S. Mg1, S. Mg1 ΔsfhA, and S. Mg1 ΔsfhA sfhA ApR were grown in liquid culture 
and had purified surfactin added to them, S. Mg1 and S. Mg1 ΔsfhA sfhA ApR were able 
to hydrolyze surfactin, while S. Mg1 ΔsfhA was unable to hydrolyze surfactin (Figure 
2.15).  While the complemented deletion mutant (S. Mg1 ΔsfhA sfhA ApR) was not able 
to hydrolyze surfactin as well as wild type S. Mg1, it was able to degrade surfactin. 
 
 
 
Figure 2.15.  MALDI-TOF spectra of S. Mg1 and derivatives with exogenous surfactin added.  The spectra 
from top to bottom are wild type S. Mg1, S. Mg1 ΔsfhA, and S. Mg1 ΔsfhA sfhA ApR.  The bacteria were 
grown in liquid culture and had purified surfactin added to 50µM after 16 hours of growth.  The cultures 
were grown for another 20 hours then extracted as described in Materials and Methods. The yellow box 
indicates the dominant isoform of surfactin, 1044 m/z peak, while the blue box indicates where the 
dominant isoform of surfactin would be hydrolyzed, the 1062 m/z peak, +18 m/z away. 
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To further confirm that the surfactin hydrolase was responsible for resistance to 
surfactin, and surfactin mediated inhibition of aerial hyphae, wild type S. Mg1, S. Mg1 
ΔsfhA, and S. Mg1 ΔsfhA sfhA ApR were plated as a lawn and had purified surfactin 
added to them (Figure 2.16).   
 
 
 
Figure 2.16.  Plate assay of S. Mg1 and derivatives with surfactin and hydrolyzed surfactin.  Wild type S. 
Mg1, S. Mg1 ΔsfhA, and S. Mg1 ΔsfhA sfhA ApR were plated with ~100µg of surfactin or hydrolyzed 
surfactin (assuming 100% recovery).  Surfactin was hydrolyzed (or not hydrolyzed) and recovered as 
described in Materials and Methods. 
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Once aerial hyphae development and spore formation occurred there is a 
dramatic phenotypic difference between the wild type and complimented deletion 
mutant versus the deletion mutant.  The inhibition of aerial hyphae in the presence of 
surfactin is seen through a lack of white pigment (associated with spore formation).  If 
hydrolyzed surfactin is applied then there is no longer inhibition of aerial hyphae 
development in the deletion mutant (Figure 2.16), further confirming that surfactin 
inhibits aerial growth and that hydrolyzing surfactin is a defense mechanism against the 
inhibition of aerial hyphae development.  While there is a clearing in the complemented 
mutant when surfactin and hydrolyzed surfactin were applied, this is inhibition of 
growth, not inhibition of aerial hyphae development.  The inhibition of growth is also 
seen faintly in the wild type S. Mg1 in Figure 2.16 and is more pronounced in the 
deletion mutant.  The inhibition of growth due to surfactin is caused by a combination of 
the antibiotic properties of surfactin with slightly different titers of spores plated.  Figure 
2.3 shows a similar inhibition of growth when surfactin was applied to wild type S. Mg1.  
What is clear is that the deletion mutant is inhibited in the formation of aerial hyphae by 
surfactin but not hydrolyzed surfactin. What little inhibition of aerial hyphae 
development there is in the deletion mutant could be from incomplete hydrolysis of 
surfactin.  For some reason the 1030 m/z peak of surfactin is not hydrolyzed as rapidly or 
completely as the other isoforms of surfactin during repeated experiments (Figures 2.6, 
2.13-2.15). 
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2.4 Discussion 
The overall goal of this project was to identify the cause of surfactin hydrolysis 
by S. Mg1.  A proposed mechanism of degradation of surfactin by S. Mg1 was that the 
organism secreted a protein which enzymatically degraded surfactin.  By analyzing 
secreted candidate proteins, cloning and expressing in a heterologous system to get a 
sufficient quantity protein uncontaminated by other S. Mg1 proteins, and in vitro trial 
assays a candidate enzyme was discovered.  This study is the first time an enzymatic 
function has been proposed through MALDI-IMS and then subsequently identified to a 
protein.  In this case the enzymatic mechanism hypothesized was that of degrading a 
xenobiotic.  S. Mg1 degrading a foreign compound with antagonistic properties against 
streptomycetes shows that the surfactin hydrolase enzyme is a resistance mechanism to 
antibiotics, giving S. Mg1 an advantage over other streptomycetes when surfactin is 
present.  A deletion of the gene encoding the enzyme resulted in a strain was no longer 
able to degrade surfactin, as seen through the lack of hydrolysis in MALDI-TOF 
analysis of cultures with surfactin added in and as a phenotypically observable trait when 
surfactin was applied to lawns of the bacteria growing. 
Further characterization of the enzyme, as being able to completely hydrolyze 
plipastatin, hints at the possibility that the enzyme could have evolved specificity against 
two B. subtilis secondary metabolites at once.  That the hydrolase changed substrate 
specificity with the addition of a divalent metal cation is also interesting.  Rather than 
losing substrate specificity for two molecules that it was previously able to hydrolyze, 
the enzyme lost specificity for one molecule but not the other, surfactin and plipastatin, 
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respectively.  The loss of surfactin hydrolysis activity implies that calcium affects the 
way surfactin aggregates such that the hydrolase no longer has access to surfactin, or to 
the ester that is needs to be hydrolyzed.  Furthermore, the presence of calcium seems to 
promote daptomycin hydrolysis.  Without calcium in the assay buffer there was barely 
any detectable daptomycin hydrolysis even after prolonged incubations with high 
concentrations of the enzyme (Figure 2.9).  After addition of calcium, hydrolysis is 
observed with reduced incubation times and in the presence of a lower concentration of 
the enzyme.  A possible explanation for any hydrolysis of daptomycin without added 
calcium could be that there were trace amounts of calcium in the buffer used, in the 
stock of the enzyme, or from contact with the containers used for the assay.  This could 
explain the distinct +18 m/z peaks, while still the extremely low rate of hydrolysis 
without added calcium.  Further credence to the role of calcium in the hydrolysis of 
daptomycin is that daptomycin has little or no activity without calcium (Baltz, et al., 
2005)  As daptoymcin is only active with calcium present, whenever an organism would 
need to develop resistance to daptomycin, an enzymatic resistance mechanism would 
also have to be active in the presence of calcium.   
The loss of specificity for one molecule, the expansion of specificity for a second 
molecule, all while maintaining specificity for a third molecule makes in an interesting 
enzyme to follow up on.  While it is designated as ‘surfactin hydrolase,’ the enzyme 
could have promiscuous activities.  If there was calcium bound to the enzyme when 
expressed, after a denaturing purification and refolding of the enzyme presumably any 
calcium would no longer be bound.  When testing the enzyme against surfactin without 
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calcium then comparing the activity to the enzyme with calcium one proposed 
explanation for a lack of activity could be that the enzyme was not evolved to have 
calcium present.  However, in the environment there is plenty of calcium around, albeit 
at lower amounts than tested (for example calcium is present in human serum at 
~1.25mM (Barry, et al., 2001)), so there is a good chance that the enzyme likely evolved 
in the presence of calcium.   
Interestingly, there is an extensive literature on surfactin interacting with 
calcium.  One study suggested that the antimicrobial activity of surfactin is dependent on 
the acyl chain length and also the charge of the peptide backbone, a charge which is 
altered in the presence of Ca2+ ions (Maget-Dana & Ptak, 1995).  Surfactin’s 
antimicrobial activity is dependent upon its ability to interact with lipids and insert itself 
into the cell membrane.  Surfactin/Ca2+ complexes insert themselves deeper into 
phospholipid bilayers than surfactin alone (Grau, et al., 1999).  When surfactin binds 
Ca2+ the calcium ion forms a bridge between the two acidic residues L-Glu and L-Asp of 
the peptide backbone (Maget-Dana, et al., 1992, Thimon, et al., 1992).  Through the 
formation of surfactin/Ca2+ complexes the antimicrobial properties are increased (Grau, 
et al., 1999) and it has been proposed that surfactin/Ca2+ complexes allow the formation 
of surfactin dimers which in turn are ion-conducting channels (Sheppard, et al., 1991).  
The hydrolase must have evolved to deal with some amount of calcium. 
Of additional interest is the difference in hydrolysis among surfactin isoforms. 
The C13 isoform of surfactin, the 1030 m/z peak seen throughout this work (which is 
+22 m/z from what the molecule would be due to a Na+), was less affected by the 
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hydrolase than other isoforms (Figures 2.6, 2.13-2.15).  One possible explanation is that 
the smaller hydrophobic tail allows tighter micelles, possibly preventing access to the 
ester by surfactin hydrolase.  While the C13 isoform represents a small fraction of 
surfactin, it may be important, especially if it is resistant to hydrolysis. 
Even though the surfactin hydrolase showed activity after denaturation and 
refolding, it is possible that its full activity is not achieved after purification. Therefore, 
more attempts need to be made to obtain soluble enzyme without the refolding step. 
Different tags like GST, MBP, and SUMO that help with solubility can be tried. If 
soluble protein is obtained, inductively coupled plasma mass spectrometry (ICP-MS) can 
be done to look for any metals associated with the enzyme. 
As the surfactin hydrolase has multiple substrates, it is possible that the substrate-
binding site is large enough that the site can bind multiple ligands at different reaction 
coordinates.  As surfactin and daptomycin were both able to be hydrolyzed, albeit at 
different levels, the enzyme could bind different ligands at higher or lower affinities 
which would affect the catalytic rate.  Many more ligands need to be examined, some 
macrolactones which may be hydrolyzed are: the Antibiotic TA, produced by 
Myxococcus xanthus; globomycin produced by a Streptomyces sp.; or krisynomycin 
produced by Streptomyces fradiae. 
Finally, B. subtilis is frequently used as a biocontrol for bacterial plant diseases 
(Ongena & Jacques, 2008, Yanez-Mendizabal, et al., 2012), as an alternative to 
fungicide use (Droby, et al., 2009), and is used in about half of the commercially based 
biopesticides (Fravel, 2005).  The main feature of B. subtilis that prevents disease is the 
 53 
 
formation of biofilms on plant surfaces (Chen, et al., 2013).  Biofilm formation is 
mediated by surfactin production and surfactin deficient B. subtilis strains are not able to 
protect plants from disease (Chen, et al., 2013).  It may be interesting to see if the 
surfactin hydrolase produced by S. Mg1 prevents B. subtilis protection from plant 
diseases. 
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CHAPTER III  
 
A POTENTIAL INDUCER OF SECONDARY METABOLISM IN STREPTOMYCES 
COELICOLOR 
 
3.1 Introduction 
3.1.1 The declining rate of discovery of new antibacterial agents 
With antibiotic-resistant infections causing health care costs of $20 billion in the 
United States alone there is need for new antibacterial agents (Bush, et al., 2011).  Soil 
bacteria from the actinomycete family, were the dominant producers of antibiotics, with 
the remaining coming mostly from fungi (Baltz, 2006).  Streptomyces, a genus 
responsible for most antibiotics produced by actinomycetes, yielded 75 new antibiotics 
per year from 1960-1980, diminishing to 20 per year between 1980 and 2000 as the 
discovery rate of ‘new’ compounds declined (Baltz, 2006).  The advent of large-scale 
combinatorial chemistry and high-throughput screening libraries has further driven drug 
companies away from traditional natural product discovery (Baltz, 2008).  However, 
more than half of the ‘new chemical entities’ discovered in the since 1981 came from 
natural products (Newman & Cragg, 2007).  The advantages of natural products, 
compared to synthesized molecules, range from their scaffold diversity to a high 
tolerance of functional groups to a much higher occurrence of novel motifs (Ganesan, 
2008).  Natural products also have an advantage over synthesized compounds in that 
natural products have undergone three billion years of evolution for activity (Baltz, 
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2008).  Of the 1184 new chemical entities described by Newman and Cragg from 1981-
2006, 52% had a natural product connection.  By applying a set of filters to screen for 
novel compounds, the authors found that just 24 unique compounds were the starting 
point for marketed drugs.  Of the 24, 5 came from plants and the remaining 19 came 
from soil bacteria, predominantly from actinomycetes (Ganesan, 2008). 
 
3.1.2 Streptomyces as reservoir of secondary metabolites 
 Within actinomycetes, the genus Streptomyces stands as a source of novel 
molecules, with two thirds of all commercial antibiotics derived from Streptomyces 
secondary metabolites (Bibb & Hesketh, 2009).  Genome mining of streptomycetes has 
shown that the secondary metabolic genetic potential of Streptomyces is largely 
untapped in the laboratory setting (Corre, et al., 2008).  Sequenced streptomycetes have 
at least 20 and sometimes up to 30 gene clusters predicted to encode for secondary 
metabolites (Baltz, 2011), the vast majority of which are not detected due to insensitive 
screening techniques (Baltz, 2008, Davies, 2010).  Standard fermentation broth 
screening apparently lacks the chemical or physical signals needed to express most 
metabolite gene clusters (Zazopoulos, et al., 2003).  This latent genetic potential, for 
“cryptic metabolites,” occupies a large amount of streptomycete genomes, in the larger 
genomes 5-10% (Baltz, 2008).  Secondary metabolites are often highly conserved within 
strains of an organism, giving credence to the idea that these metabolites confer an 
adaptive advantage (Borodina, et al., 2005).  In S. coelicolor at least 23 secondary 
metabolite gene clusters occupy 5% of the 8.7MB genome (Bentley, et al., 2002).  Only 
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6 metabolites have been isolated, four antibiotics: methylenomycin A, calcium-
dependent antibiotic, undecylprodigiosin and actinorhodin; as well as two other 
molecules: coelichelin, a new siderophore (Challis, 2008, Xu, et al., 2010), and a group 
of molecules, germicidins, which inhibit spore germination (Aoki, et al., 2011).   
 
3.1.3 Techniques used to ‘awaken’ cryptic secondary metabolites 
Varying conditions to mimic environment cues have been used in traditional 
fermentation screenings to ‘awaken’ the cryptic gene clusters responsible for secondary 
metabolism.  Traditional approaches to awaken cryptic metabolites include altering 
nutrient sources (Martin, et al., 2011), over-expressing activators (Baltz, 2010), deleting 
putative negative regulators (Gottelt, et al., 2010), an extensive amount of single gene 
knockouts (Castro-Melchor, et al., 2010), heterologous expression of cryptic gene 
clusters (Widdick, et al., 2003), transposon mutagenesis to either knockout or upregulate 
various genes (Bibb & Hesketh, 2009), making multiple copies of a particular gene 
cluster within a genome (Murakami, et al., 2011), knocking out other secondary 
metabolite gene clusters which compete for precursors (Komatsu, et al., 2010, Gomez-
Escribano & Bibb, 2011), or mutagenizing the genome to get higher yields (Inaoka, et 
al., 2004, Wang, et al., 2008, Inaoka & Ochi, 2011).  Secondary metabolites come from 
the redirection of intermediates in primary metabolism into alternative pathways 
(Murakami, et al., 2011).  Thus another approach has been to chemically stimulate 
various streptomycetes so their primary metabolism is perturbed in such a way that some 
secondary metabolism is altered or increased (Craney, et al., 2012). 
 57 
 
 
3.1.4 Co-cultures of bacteria to elicit cryptic metabolites 
An alternative way of studying secondary metabolism has been to induce a 
metabolic shift by perturbing one organism with another.  This co-culture method has 
been used to put stress upon an organism, which could occur in the environment but 
would not otherwise occur in a laboratory.  There are tens of studies showing induction 
of secondary metabolism in fungi and bacteria due to co-culture stress (Patterson & 
Bolis, 1997, Burgess, et al., 1999, Ueda, et al., 2000, Cueto, et al., 2001, Onaka, et al., 
2001, Santamaria, et al., 2002, Trischman, et al., 2004, Yamanaka, et al., 2005, Angell, 
et al., 2006, Miao, et al., 2006, Oh, et al., 2007, Siemieniewicz & Schrempf, 2007, 
Schroeckh, et al., 2009, Amano, et al., 2010, Li, et al., 2010, Liu, et al., 2010, Amano, et 
al., 2011, Li, et al., 2011, Luti & Mavituna, 2011, Luti & Mavituna, 2011, Onaka, et al., 
2011, Perez, et al., 2011, Zuck, et al., 2011, Traxler, et al., 2012).  The most abundant 
studies pair marine microbes together to see induction of a metabolite absent in 
monoculture or either strain.  Among the studies that focus on streptomycetes there is a 
similar pattern, for instance Ueda et al. showed, that from 45 fresh soil isolates of 
streptomycetes, 98% either increased antibiotic production or triggered early sporulation 
in other streptomycetes (Ueda, et al., 2000).  While these studies are informative to show 
that bacteria can and do interact with their neighbors by triggering or responding to 
chemical stressors, there is little mechanistic for the basis of induction. 
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3.1.5 Co-cultures with model organisms to mechanistically understand elicitation 
To study the induction of secondary metabolism through bacterial interactions, 
we have taken the same approach of co-culturing in an artificial setting.  However, we 
are using two soil-dwelling model organisms, Bacillus subtilis and Streptomyces 
coelicolor.  We are using model organisms for two reasons: as they coexist in the 
environment they are likely to interact and evolve against each other; they are also well 
studied, so deeper mechanistic observations can be made and compared to other closely 
related organisms (Straight, et al., 2006, Straight, et al., 2007).  As model organisms 
they have both been extensively studied in monoculture, much about how they interact 
with neighboring organisms is unknown.  Previous studies have shown that S. coelicolor 
is affected by the presence of B. subtilis (Straight, et al., 2006, Straight, et al., 2007, Liu, 
et al., 2010, Luti & Mavituna, 2011).  One previously studied interaction involves a 
cyclic lipopeptide, surfactin, produced by B. subtilis.  Surfactin, required for raising 
aerial hyphae and thus formation of biofilms in B. subtilis, actually inhibits the 
development of aerial hyphae in S. coelicolor (Straight, et al., 2006).  By blocking the 
development of aerial hyphae, and thus spore production, B. subtilis is reducing 
competitors for nutrients for its own offspring spores.  This could represent an offensive 
mechanism by which B. subtilis inhibits completion of S. coelicolor’s lifecycle.  
However, surfactin is also used by B. subtilis for swarming across solid surfaces (Kearns 
& Losick, 2003).  Since surfactin has multiple intraspecific and interspecific roles in 
culture, a single environmentally relevant function is not defined. 
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 S. coelicolor and B. subtilis have many other chemical interactions.  Another 
example involves a different B. subtilis metabolite, bacillaene.  When cultured together 
there is ‘a rather unremarkable’ phenotype (Straight, et al., 2007), with S. coelicolor 
growing right up to the edge of the B. subtilis colony.  Transposon mutagenesis of B. 
subtilis revealed bacillaene deficient strains when paired against S. coelicolor cause 
there to be early production of undecylprodigiosin by S. coelicolor (Figure 1) (Straight, 
et al., 2007).  Undecylprodigiosin (RED) has immunosuppressive and anticancer 
activities as well as published antifungal, antibacterial, and antiprotozoal properties 
(Williamson, et al., 2006).  The chemical exchange leading to an early induction of RED 
is interesting because S. coelicolor is able to sense a neighboring organism and turn on 
production of a secondary metabolite, presumably in defense.  Production of RED has 
since been elicited with living or dead B. subtilis cells (Luti & Mavituna, 2011) as well 
as with Staphylococcus aureus heat-inactivated cells (Luti & Mavituna, 2011).  But the 
mechanism of early induction of RED is unknown. 
  
 60 
 
 
Figure 3.1.  RED induction in S. coelicolor from bacillaene deficient strains of B. subtilis.  Left panel: 
wild-type undomesticated strain B. subtilis, NCIB 3610 producing bacillaene, does not induce RED in co-
culture with S. coelicolor.  Right panel: a bacillaene deficient mutant of the 3610 induces early production 
of RED in co-culture with S. coelicolor. 
 
 
3.1.6 RED induction 
 RED has antifungal, antibacterial, and antiprotozoal properties (Williamson, et 
al., 2006), but these roles only apply at the latter end of S. coelicolor’s lifecycle, to 
protect the nutrients from degraded vegetative mycelia for the spore forming aerial 
hyphae from any motile competitors (Bibb, 2005).  However since the pigment is largely 
localized intracellularly, none of these reported functions address a physiological role 
(Haddix, et al., 2008).  Several intracellular roles have been suggested: as an energy 
spilling function by reducing ATP production (Haddix, et al., 2008), as a metabolic sink 
for proline or NAD(P)H (Hood, et al., 1992), as a bacterial dispersal agent due to its 
surface association (Syzdek, 1985), as a UV-protective pigment (Boric, et al., 2011) and 
most recently as an antioxidant (Stankovic, et al., 2012).  RED production is turned on 
 61 
 
by a quorum-sensing mechanism and a variety of nutritional conditions as summarized 
in a recent review (Williamson, et al., 2006).  RED itself is also able to be sensed by S. 
coelicolor in a mechanism to coordinate timing of antibiotic production within a colony 
(Xu, et al., 2010).  With regard to its antimicrobial properties, RED has been reported to 
inhibit growth of Mycobacterium smegmatis, Streptomyces somaliensis, Staphylococcus 
aureus (Gerber, 1975), Bacillus sp. (Staric, et al., 2010), and even B. subtilis (Stankovic, 
et al., 2012), among other microorganisms (Gerber, 1975, Stankovic, et al., 2012).  The 
induction of RED when challenged to Bacillus subtilis and Staphylococcus aureus 
implies that S. coelicolor is sensing a competitor and responding to it (Straight, et al., 
2007, Yang, et al., 2009, Luti & Mavituna, 2011, Luti & Mavituna, 2011).  What 
interests our study is the induction of RED when challenged by another organism, so that 
we can establish a mechanism of response by the model streptomycete to a competitor.  
If we were to establish such a mechanism based off a molecular cue, then we will use 
that cue to elicit cryptic metabolites in other streptomycetes. 
 
3.1.7 Transposon screen reveals candidate genes related to the induction of RED 
The early onset of RED is most likely due to S. coelicolor sensing the chemical 
presence of a competitor, in this case sensing a compound secreted by B. subtilis.  If S. 
coelicolor turned on RED as a result of a decrease in nutrients caused by competition 
with B. subtilis then RED induction would always occur in the absence of bacillaene.  
However, a second transposon mutagenesis screen revealed that there are mutations in B. 
subtilis which lead to a loss of early induction of RED phenotype when the organisms 
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are co-cultured together (Figure 3.2).  This has led to the hypothesis that there is a 
secreted metabolite which induces RED (Figure 1 right panel).  Alternatively, the 
bacillaene deficient strains of B. subtilis may be altered in their metabolic flux such that 
a molecule normally present in minute quantities is overproduced when bacillaene is not 
produced, allowing it to be in a sufficient quantity to be sensed by S. coelicolor.   
 
 
 
Figure 3.2.  Transposon mutagenesis of Bacillus subtilis reveals possible inducer molecules of RED in S. 
coelicolor.  This is seen through a decreased level of RED production compared to wild type PY79 B. 
subtilis (WT).  CymR: cysteine-metabolism regulator; bacB: bacilysin synthase; gltAB: glutamate synthase 
AB; ymfI: alcohol dehydrogenase required for neotrehalosadiamine production. 
 
 
 In the absence of bacillaene there is early induction of RED, presumably because 
B. subtilis is producing and secreting more of the inducing molecule.  The second 
transposon screen used another B. subtilis strain, PY79, a domesticated strain that does 
not produce a number of secondary metabolites including bacillaene, revealed several 
genes which when disrupted altered the early onset of RED.   The best candidate genes 
for altered induction of RED (seen in Figure 3.2) include: cymR, cysteine-metabolism 
repressor, a global regulatory factor for sulfur metabolism (Even, et al., 2006); gltAB, 
the two of which comprise glutamate synthase (Picossi, et al., 2007); ymfI, involved in 
 63 
 
swarming and predicted to encode a short chain alcohol dehydrogenase for a precursor 
of neotrehalosadiamine (Kearns, et al., 2004, Inaoka & Ochi, 2007); and bacB, involved 
in bacilysin biosynthesis (Parker & Walsh, 2012).  The effects of each mutation on the 
metabolic flux within B. subtilis causes either the reduction or abolition of production of 
the molecule(s) which causes S. coelicolor to turn on RED early. 
 
3.2 Materials and Methods 
3.2.1 Bacterial strains 
The strains used in this chapter are listed in Table 3.1.  For long term storage 
Escherichia coli strains were grown overnight, spun down, and resuspended in sterile 
20% (v/v) glycerol, and stored at -80°C.  For streptomycetes the spore suspensions were 
prepared in sterile mqH2O then stored at -80°C.  Spore suspensions of Streptomyces 
coelicolor were prepared using previously established protocols (Kieser, et al., 2000).  
Briefly, a -80°C stock of the streptomycete was struck out in a square-like pattern onto a 
R5 plate (Kieser, et al., 2000), once spore formation occurred (~3-4 days) 1mL of sterile 
mqH2O was applied to the plate and spores were scraped with a cell scraper, removed 
and 1mL more of sterile mqH2O was applied and taken off with a pipette.  The spores 
were serially diluted in sterile mqH2O and plated on GYM plates to get a working titer 
for experiments. 
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Table 3.1.  Bacterial strains used in this chapter. 
Strain Relevant Genotype 
PDS0066 Bacillus subtilis NCIB3610 wild type 
PDS0067 Bacillus subtilis NCIB3610 Δpks 
PSK0028 Streptomyces coelicolor M145 
PDS0288 
Streptomyces coelicolor M145 dasR::aacC4 from van 
Wezel (Rigali, et al., 2006) 
PSK0453 Bacillus subtilis NCIB3610 ΔbacB 
PDS0371 Bacillus subtilis NCIB3610 Δpks, ΔscoC, ΔabrB 
PDS0375 Bacillus subtilis NCIB3610 Δpks, ΔscoC, ΔabrB, ΔbacB 
PSK0015 Bacillus subtilis 168 wild type 
PSK0001 Bacillus subtilis PY79 wild type 
 Bacillus subtilis PY79 ΔbacB 
 
 
3.2.2 Media 
Bacto media was used, unless otherwise noted.  Luria-Bertoni (LB) broth (1% 
w/v tryptone, 0.5% w/v yeast extract, and 0.5% w/v NaCl) was used for Bacillus subtilis 
cultures, with LB plates having 1.5% agar added.  LB was supplemented with 10µg/mL 
kanamycin, 5µg/mL chloramphenicol, 100µg/mL spectinomycin, 10µg/mL tetracycline, 
and MLS (1µg/mL of erythromycin, 25µg/mL of lincomycin) as appropriate.  All 
antibiotics used were purchased from Sigma.  Streptomyces spp. cultures were grown on 
glucose-yeast-malt extract (GYM) (1% w/v malt extract, 0.4% w/v yeast extract, 0.4% 
w/v dextrose) with GYM plates having 1.5% agar added. 
PA media for production of bacilysin (Walker & Abraham, 1970) and the 
inducing molecule was modified to included 1mM GlcNAc (Sigma) and 100mM 
morpholinepropanesulfonic acid (MOPS) pH 6.8.  GlcNAc addition was to prevent 
autolysis of B. subtilis PY79 as a result of over-production of bacilysin.  MOPS was to 
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maintain pH during growth and production of the inducing compound.  PA recipe: 
KH2PO4 - 1.1g,  MgSO4·6H2O - 0.975g, KCl - 0.55g, monosodium glutamate - 4.4g, 
sucrose - 13.7g, 1M MOPS pH 6.8 - 100ml, oligodynamic solution - 1ml, brought to 
~992.5ml and filter sterilized.  After filter sterilizing 7.5ml of ferric citrate (20mg/ml 
ferric chloride, 20mg/ml sodium citrate, filter sterilized) was added.  Oligodynamic 
solution was prepared as previously described (Pollock & Kramer, 1958). 
 
3.2.3 Co-cultures of B. subtilis and S. coelicolor 
 Fresh LB plates, plus appropriate antibiotics, were allowed to dry, streaked with 
B. subtilis strains from -80°C glycerol stocks.  Plates were incubated overnight at 37°C, 
removed to room temperature (~22°C) and used within 3-4 days to make overnight 
liquid cultures in LB (incubated at 37°C and ~200rpm).  32mL GYM plates were made 
using a glass pipette and after all plates were made the lids were removed and plates 
allowed to dry for 20 minutes.  Plates used for co-cultures were stored for up to a month 
at 4°C.  Upon use for co-culture the plates were dried for 20 minutes, plated with 100µL 
of varying dilutions of S. coelicolor using glass beads, glass beads removed and plates 
allowed to dry for 20 minutes more.  Then 1-2µL of overnight B. subtilis cultures were 
spotted in the middle of the plate.  Plates were incubated at 30°C until desired 
development was observed. 
 
  
 66 
 
3.2.4 Preparation of B. subtilis lyophilized supernatants 
 B. subtilis cultures were struck out onto fresh LB plates, plus appropriate 
antibiotics when necessary.  Overnight B. subtilis cultures were inoculated from 1-4 day 
old plates and grown at 30°C and ~200rpm, in PA media with 1mM GlcNAc.  The 
overnight culture was used get 1L of the same media to an OD600 = 0.02 (500ml each in 
a 2.8l baffled flask).  Cultures were grown for 24 or 48hrs, shaking at 200-225rpm.  
Cells were pelleted at 4,000 x g for 30min at 4°C and discarded.  Supernatants were 
flash frozen and lyophilized, then resuspended in mqH2O at 1:25 of the original volume, 
then filter sterilized through a 0.2µm filter. 
 
3.2.5 Preparation of B. subtilis crude extracts 
 Using a previously established protocol for bacilysin production (Parker & 
Walsh, 2012), extracts were prepared.  Overnight B. subtilis cultures were grown at 30°C 
in PA media with 1mM GlcNAc.  The overnight culture was used get 1L of the same 
media to an OD600 = 0.02 (500ml each in a 2.8l baffled flask).  Cultures were grown for 
48hrs, shaking at 200-225rpm.  Cells were pelleted at 4,000 x g for 30min at 4°C and 
discarded.  To the supernatant 1L ethanol was added (to get 50% v/v).  The mixture was 
shaken thoroughly and incubated at 4°C overnight.  Precipitated proteins and DNA were 
pelleted at 4,000 x g for 30min at 4°C and discarded.  Supernatants were applied to a 
Dowex 50WX8-200 cation exchange resin (Sigma), pre-equilibrated with 50% ethanol.  
~25g resin was used per each column. Washed each column with ~5 column volumes of 
water (~100ml), eluted each column with 40 mL of 4% NH4OH in H2O into 2 50ml 
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conical cylinders submerged in liquid nitrogen.  The elution was lyophilized to dryness, 
resuspended in smallest volume of mqH2O possible, 1-2mL. 
 
3.2.6 Plating extracts from B. subtilis against S. coelicolor 
S. coelicolor was plated as described in section 3.2.3.  Filter sterilized extracts 
were plated after S. coelicolor spores had dried and plates were allowed to dry for 
another 20 minutes. 
 
3.2.7 Fractionation of B. subtilis extracts 
 Pre-wetted SPE cartridges C8, C18, diol, cyano, NH2, and silica SPE cartridges 
(Sigma), or their resins were loaded with Dowex eluted B. subtilis extracts from wild-
type PY79 or ΔbacB PY79.  C8, C18, and NH2 cartridges were pre-wetted by running 
3mL of methanol then 3mL of 20% methanol/water v/v, then 6mL of water.  To elute 
various fractions 10mL fractions were used moving up in steps 10% methanol/water v/v, 
increasing by 10% methanol steps were used.  Samples were concentrated to dryness 
under pressure then resuspended in mqH2O, filter sterilized through a 0.2µm filter, and 
plated.  Diol, cyano, and silica cartridges were pre-wetted with 3mL of methanol then 
3mL of 20% methanol/chloroform v/v, then 6mL of chloroform.  Samples were 
lyophilized to dryness, resuspended in chloroform, then loaded onto the cartridges.  
Samples were eluted off of the cartridges in 10ml 10% methanol/chloroform steps until 
the methanol/chloroform ratio was 100:0.  Fractions were concentrated to dryness under 
pressure then resuspended in mqH2O, filter sterilized through a 0.2µm filter, and plated. 
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3.3 Results and Discussion 
3.3.1 Bacilysin as an inducer of RED 
 From the transposon mutagenesis screen, two genes are directly involved in the 
production of secondary metabolites: bacB and ymfI.  The other genes which were 
identified in the screen were more general metabolic or regulatory genes, not associated 
with a particular secondary metabolite.  ymfI when plated in a co-culture at varying 
densities of spores was subsequently shown to induce RED (data not shown).  The bacB 
gene is involved in the biosynthesis of bacilysin.  When plating lyophilized supernatants 
of wild type B. subtilis and ΔbacB B. subtilis there was induction of RED for wild type, 
but not for ΔbacB (Figure 3.3). 
 
 
 
Figure 3.3.  Lyophilized supernatants of B. subtilis plated against S. coelicolor.  Wild-type PY79 and 
ΔbacB PY79 were grown in PA media for 48hrs, spun down, the supernatant lyophilized and resuspended 
in 1/25 the volume and 20µL plated onto filter discs (white circles seen above). 
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The induction of RED by wild-type PY79, but not ΔbacB lyophilized 
supernatants led us to believe bacilysin was the inducing molecule.  The bacB gene is 
directly involved in the biosynthesis of bacilysin (Rajavel, et al., 2009), a dipeptide 
antibiotic which is taken up into a host and cleaved releasing the non-canonical amino 
acid anticapsin (Chmara, 1985).  Anticapsin, which mimics L-glutamine, irreversibly 
binds to glucosamine synthase, which is required for cell wall biosynthesis (Chmara, 
1985).  This is a direct link to a S. coelicolor master regulator DasR, which controls, 
among other functions, secondary metabolism (Rigali, et al., 2008).  Previously this 
regulator has been shown to be involved in sensing nutrient stress, as it represses 
antibiotic production in rich media, but releases the promoters of its regulon when bound 
by glucosamine-6-phosphate (GlcN-6-P), the product of glucosamine synthase (Chmara, 
1985, Rigali, et al., 2008).  While halting the production of a molecule which alters the 
activity of a repressor of antibiotic production would seem counter to elicitation of 
secondary metabolites, not all of the dynamics of the DasR system are fully understood 
yet (van Wezel & McDowall, 2011, Swiatek, et al., 2012, Swiatek, et al., 2012).   
During sporulation, aerial hyphae are raised above the vegetative mycelia and 
cannibalize the mycelia below for nutrients (van Wezel & McDowall, 2011).  Tying 
sporulation to production of antibiotics protects nutrients from motile organisms which 
might compete with the spore-forming organism (Chater, et al., 2002).  Bacilysin was 
looked at as an environmental stress, by mimicking a lower level of GlcN-6-P in S. 
coelicolor’s overall metabolic flux.  This would cause S. coelicolor to proceed ahead in 
its developmental processes, including antibiotic production.  We hypothesized bacilysin 
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to be the inducing molecule as it a direct link to a global antibiotic regulator, DasR, and 
there was no direct link for our other candidate molecule, NTD.  A previous study on the 
interaction between undomesticated B. subtilis and S. coelicolor using imaging mass 
spectrometry did not support the hypothesis of bacilysin as the inducing molecule (Yang, 
et al., 2009).  Experimental conditions have long been known to impact production of 
secondary metabolites (Gonzalez, et al., 2012).  The previous study used different 
conditions: media, starting inoculums of the two strains, monitored at a different timing, 
and importantly used different strains (sfp- instead of ∆pks to knock out bacillaene 
production).   
 
3.3.2 Identification of a B. subtilis strain which over-produces bacilysin 
 In an effort to purify bacilysin to test for inducing activity against S. coelicolor 
several strains of B. subtilis were examined for their bacilysin production characteristics.  
Reports on bacilysin regulation suggest that scoC and abrB negatively regulate bacilysin 
production (Karatas, et al., 2003, Inaoka, et al., 2009).  Bacilysin also appears to be 
produced at higher levels in a Δpks background of B. subtilis, a strain which no longer 
produces bacillaene (data not shown).  A strain of B. subtilis 3610 was constructed with 
pks, scoC, and abrB deletions to see if bacilysin was overproduced.  This was compared 
to a similar strain with an additional bacB mutation, as a negative control to show the 
abolishment of bacilysin production.  Further comparison against B. subtilis strains 
included the ‘undomesticated’ parental strain, NCIB 3610, a derivative with bacB 
deleted, again to show abolishment of bacilysin production, and a ‘domesticated’ strain, 
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B. subtilis 168.  These strains were grown in PA media and lyophilized supernatants 
analyzed via LC/MS for bacilysin production as seen in Figure 3.4 (Courtesy of Jared 
Parker of the Walsh laboratory, Harvard). 
 
 
 
Figure 3.4.  Bacilysin production in various B. subtilis strains.  Strains are listed at the top right for each 
spectra.  Bacilysin, and a similar compound, chlorotetatine are shown when produced in sufficient 
quantities.   
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 Interestingly, the undomesticated strain of B. subtilis, NCIB3610, produced 
bacilysin at barely detectable levels in these assays.  The triple mutant, Δpks, ΔscoC, and 
ΔabrB, showed higher levels of bacilysin production, as would be expected with the 
deletion of two regulators, scoC and abrB, combined with the deletion of portions of the 
pks gene cluster, responsible for the production of bacillaene.  By no longer producing 
bacillaene there may be less competition for precursor molecules to bacilysin 
biosynthesis.  What is intriguing is the overproduction of bacilysin by the domesticated 
strain B. subtilis 168.  B. subtilis 168, a laboratory strain derived from NCIB3610, does 
not produce the three major secondary metabolites that NCIB3610 produces: surfactin, 
plipastatin, or bacillaene.   
 
3.3.3 Determining experimental parameters to see production/ induction of RED 
 In order to systematically monitor the induction of RED, which is a normal 
developmental process of S. coelicolor, S. coelicolor was plated on several different 
media and observed for production of RED.  R5 media caused S. coelicolor to develop 
rapidly such that RED production was seen within 24 hours at some plating dilutions of 
spores, and the plates were blue or dark purple shortly thereafter, from actinorhodin 
production (data not shown).  Actinorhodin is produced at much higher levels than RED 
(van Wezel & McDowall, 2011).  When the timescale of actinorhodin production is 
accelerated it is harder to see induction of RED, so RED induction was monitored on 
GYM, to delay induction of ACT (Sanchez, et al., 2010).  At the lower plating densities 
of spores from S. coelicolor RED production takes several days (Figure 3.4).  As RED is 
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a normal development process all colonies of S. coelicolor eventually start producing 
RED.  At plating densities lower than a lawn there are some colonies which turn on 
production of RED faster than others, presumably due to factors unrelated to genetics, 
note the half of a colony in the top left quadrant of each image which is redder than the 
rest of the plate (Figure 3.4). 
 
 
 
Figure 3.4 Low plating densities of S. coelicolor show that all colonies turn on RED production.  A plate 
of S. coelicolor with a spore plating density of ~102 was monitored for RED production over one week, 
incubated at 30°C. 
 
 
 In order to determine the fastest time RED is induced, S. coelicolor was plated at 
different spore titers and observed daily for a week (Figure 3.5).  A time course of 
images was taken of S. coelicolor plated at different spore densities, and a representative 
image is shown.  This was to determine when RED production normally occurred so as 
to be able to monitor early induction of RED.  At higher plating densities RED 
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production turned on earlier, which is indicative of dependence on the stage of S. 
coelicolor development (Williamson, et al., 2006).   
 
 
 
Figure 3.5 Density dependent production of RED.  Six different titers of S. coelicolor M145 spores were 
plated and monitored for developmental changes, such as RED and ACT production, as well as spore 
formation. 
 
 
3.3.4 B. subtilis Dowex elutions induce RED 
As RED production was first observed at 40-42 hours at the highest plating 
density, 107 spores per plate, this plating density was chosen for future experiments in 
order to speed up the timescale to results.  To observe the induction of RED from B. 
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subtilis extracts a dowex elution (see Materials and Methods) was applied to the highest 
plating density of S. coelicolor and observed for one week (Figure 3.6).  Since B. subtilis 
168, the domesticated strain, had the highest levels of bacilysin production, all future 
experiments are done with another domesticated B. subtilis strain, PY79, which is 
derived from 168 but does not have the auxotrophies of 168 (Zeigler, et al., 2008).  
There was no discernable difference between B. subtilis 168 and B. subtilis PY79 in co-
cultures with S. coelicolor or when their extracts were plated against S. coelicolor (data 
not shown).  S. coelicolor turned on RED production around 42hrs when untreated.  
With B. subtilis extracts applied to S. coelicolor there was induction of RED before 
37hrs, as seen by the bright red dot in the center of the 37hr image.  Interestingly there 
was spore formation where the B. subtilis extracts were applied to S. coelicolor, when S. 
coelicolor rarely forms spores on GYM (as seen through a white pigment, characteristic 
of spore formation).  A developmental link between antibiotic production and spore 
formation in S. coelicolor has been seen previously (Ueda, et al., 2000, Perez, et al., 
2011). 
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Figure 3.6.  Induction of RED and spore formation in S. coelicolor when B. subtilis Dowex elutions are 
applied.  107 spores of S. coelicolor were plated onto GYM and spotted with Dowex elutions from B. 
subtilis. 
 
 
3.3.5 Determining if bacilysin is the inducer of RED 
In order to determine if bacilysin is the inducer of RED, as is hypothesized, 
purified bacilysin was plated on S. coelicolor (Figure 3.7); bacilysin was graciously 
donated by Jared Parker.  When 20µg of purified bacilysin was applied to S. coelicolor, 
there was no induction of RED after 36hrs (Figure 3.7) or at later time points (data not 
shown).  To confirm bacilysin was in an active form, it was also plated against a 
sensitive organism, as Staphylococcus aureus is used as a tester strain in many studies on 
bacilysin (Walker & Abraham, 1970, Perry & Abraham, 1979).  There was killing of S. 
aureus (data not shown), confirming bacilysin was active even though there was no 
induction of RED in Streptomyces coelicolor.  As a positive control for induction, 
Dowex elutions were again applied to S. coelicolor, showing induction of RED.  To 
reaffirm the link to bacilysin (or at least bacB) Dowex elutions from a bacB background 
in PY79 showed no induction of RED (Figure 3.7). 
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Figure 3.8.  Bacilysin does not induce RED but the B. subtilis PY79 Dowex elution does.  107 spores of S. 
coelicolor were plated onto GYM and spotted with water, 20µg bacilysin (courtesy of Jared Parker) or 
Dowex elutions from B. subtilis PY79 wild type and ΔbacB. 
 
 
 Our proposed link between bacilysin and induction of RED was a regulatory 
gene in S. coelicolor, DasR.  DasR, as previously stated, controls many processes within 
S. coelicolor, including regulation of the four most studied secondary metabolites of S. 
coelicolor, RED, ACT, CDA, and cpk (cryptic yellow polyketide) (Rigali, et al., 2008).  
DasR had been shown to be involved in sensing nutrient stress but was repressed when 
bound by glucosamine-6-phosphate, the product of glucosamine synthase (Chmara, 
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1985, Rigali, et al., 2008).  While bacilysin inhibited production of GlcN-6-P we 
theorized that the link might be more complicated.  Once bacilysin was shown to not be 
the inducer of RED we still wanted to test the dasR connection.  When testing the dasR 
mutant (BAP29 from van Wezel) we saw that RED was still induced by B. subtilis 
extracts (Figure 3.9), therefore, the master regulator DasR is not involved in the B. 
subtilis mediated RED induction. 
 
 
 
Figure 3.9.  Dowex elutions from wild type B. subtilis PY79 plated on wild type and dasR S. coelicolor 
M145.  There is no loss of induction of RED when the master regulator DasR is disrupted. 
 
 
 
While the master regulator DasR is not involved in induction of RED by B. 
subtilis, there potentially is a link to a morphogenesis regulator.  Observing the same 
plates spotted with Dowex elutions from wild type and ΔbacB B. subtilis PY79, over an 
extended time course, similar to Figure 3.6, showed an interesting result.  A sporulation 
inducing compound was present in wild type B. subtilis extracts, but not in ΔbacB 
(Figure 3.10).  This molecule could be the same compound as the RED inducing 
compound or it could be another compound.  There have been reports of developmental 
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links between secondary metabolite production and sporulation (Perez, et al., 2011, van 
Wezel & McDowall, 2011). 
 
 
 
Figure 3.10.  B. subtilis Dowex elutions contain an inducer of morphogenesis. 107 spores of S. coelicolor 
were plated onto GYM and spotted with Dowex elutions from B. subtilis PY79 wild type and ΔbacB.  
These are the same plates from Figure 3.8 but after ~140hrs. 
 
 
As bacilysin is not the inducing molecule there could be multiple reasons why 
the inducing molecule is no longer produced in a bacB strain.  When bacilysin is not 
made either precursors of bacilysin are shunted into another metabolic pathway or 
byproducts of bacilysin production are also no longer made, such that the inducing 
molecule is then deprived of some component.  Alternatively bacilysin could have an 
intracellular signaling role within B. subtilis which has not been elucidated.  Bacilysin 
inhibits glmS (Chmara, 1985), it has yet to be shown if bacilysin inhibits one or both of 
B. subtilis’s two glmS enzymes.  If bacilysin did inhibit either of the enzymes then this 
could cause a developmental transition within B. subtilis, possibly when the organism 
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slows down growth (resulting from depletion of glucosamine-6-phosphate).  Due to the 
genetics in the deletion of bacB, another possibility could simply be that either bacB or 
one of the downstream genes in the bac operon is involved in the biosynthesis of the 
inducing molecule.  The deletion of bacB was done with a resistance marker and 
multiple transcriptional terminators inserted in place of the gene.  As bacB is the second 
gene of the six gene operon, it is impossible to tell which gene downstream of bacB 
could be involved in production of the inducing molecule (Inaoka, et al., 2003, 
Steinborn, et al., 2005). 
 
3.3.6 Determining purification conditions for the inducer of RED 
 When comparing wild type and bacB Dowex elutions via LC/MS there was no 
detectable molecule in wild type B. subtilis that was not also in ΔbacB (work done by 
Jared Parker, data not shown).  In order to purify the inducer of RED a new purification 
step in the purification strategy needed to be developed before LC/MS to detect a 
difference between wild type and ΔbacB, because there is a phenotypic difference in S. 
coelicolor when plated with the different Dowex elutions (Figure 3.8 and 3.10).   
One step which produced an observable difference was growing B. subtilis for 
48hrs as opposed to 24hrs.  Dowex elutions were prepared from wild type and ΔbacB B. 
subtilis PY79 and plated at different dilutions (Figure 3.11).  Unlike previous Dowex 
elutions, there was a faint zone where ΔbacB induced RED.  The ΔbacB strain also 
produced higher levels of some kind of antibiotic which inhibited the growth of S. 
coelicolor.  There is also an inhibition of growth in the wild type Dowex elution, as seen 
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by a light clearing and lower production of RED where the Dowex elution was applied, 
which decreases as the elution is diluted (Figure 3.11 WT 1x to 0.25x dilutions, note the 
intensity of RED at the center).  The production of a growth inhibiting factor was seen 
for wild type as well as ΔbacB (Figure 3.8) especially if the Dowex elution was at higher 
concentrations (data not shown).  When plating the Dowex elutions against a lower titer 
of S. coelicolor spores there is killing (or inhibition of growth) for both wild type and 
ΔbacB, although there is no induction of RED in ΔbacB.  The lack of induction of RED 
from ΔbacB at a lower titer of spores is presumably due to the delayed developmental 
process, as was seen for lower titers of spores in Figure 3.5. 
 
 
 
Figure 3.11.  Dowex elutions from wild type and ΔbacB after 48hrs of B. subtilis growth.  107 spores 
(Panel A) or 106 spores (Panel B) of S. coelicolor were plated onto GYM and spotted with Dowex elutions 
from B. subtilis PY79 wild type and ΔbacB.  The weird shape in panel B, ΔbacB applied with 1x Dowex 
elution is presumably due to the incomplete drying and the liquid spreading when the plate was inverted. 
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 To better understand the nature of the inducing molecule supernatants from wild 
type and ΔbacB B. subtilis PY79 were extracted with a variety of solvents which ranged 
in polarity, dried under pressure, filter sterilized and plated (Figure 3.12).  When plated 
against S. coelicolor hexanes, butanol, and chloroform extracts of wild type PY79 
showed induction of RED, while only the butanol extract of ΔbacB showed induction of 
RED.  This is additional evidence that ΔbacB produces the inducing molecule, just in 
concentrations much lower than wild type B. subtilis.  Of note is that there is again 
production of some antimicrobial/growth inhibiting compound, and it is produced at 
higher levels in ΔbacB than wild type B. subtilis.   
 
 
 
Figure 3.12.  Solvent extractions of B. subtilis supernatants plated against S. coelicolor.  107 spores of S. 
coelicolor were plated onto GYM and spotted with solvent extractions of wild type and ΔbacB B. subtilis 
supernatants from cultures grown in PA media. 
 
 
 A series of co-culture experiments between S. coelicolor and B. subtilis PY79, 
wild type and ΔbacB further showed that ΔbacB produces the inducing molecule, as seen 
 83 
 
through plating the B. subtilis strains against S. coelicolor at a high plating density of 
spores (Figure 3.13).  Decreased levels of the inducing molecule produced by ΔbacB 
may have not induced RED production at low levels of spores, but at higher levels of 
spores there was clearly induction (Figure 3.13 bottom vs. top panels).  While there is 
less induction of RED in the lower dilution of S. coelicolor spores compared to the 
higher dilution, there is more induction in co-cultures of wild type B. subtilis compared 
to ΔbacB B. subtilis. 
 
 
 
Figure 3.13.  Co-cultures of wild type and ΔbacB B. subtilis PY79 versus different spore densities of S. 
coelicolor. 107 or 106 spores of S. coelicolor were plated onto GYM and spotted with overnight cultures of 
wild type and ΔbacB B. subtilis grown in PA media. 
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3.3.7 Fractionation of Dowex elutions to further isolate the inducer of RED 
 After it was determined that ΔbacB B. subtilis still produces the inducing 
molecule steps were taken to isolate the inducing molecule from wild type B. subtilis but 
not ΔbacB.  In order to deduce some molecular properties of the molecule a variety of 
tests were performed on Dowex elutions from wild type B. subtilis.  The elutions were 
boiled and subjected to ProteinaseK treatments to see if the molecule was proteinaceous, 
in both cases the inducing molecule was resistant to the treatments, indicating that it was 
not a large peptide (data not shown).  Dowex elutions brought up to a high pH (>12) 
were still able to induce RED (data not shown), indicating that the molecule is somewhat 
stable in the presence of basic conditions.  Dowex elutions were also dried under 
pressure and resuspended in various organic solvents in order to d solubility of the 
molecule for later use in extractions.  The resuspensions were spun down and the 
supernatants removed from the pellets.  Both fractions were dried under pressure, 
resuspended in water and filter sterilized.  When plated against S. coelicolor the inducing 
molecule appeared to be soluble in only two solvents, chloroform and methanol (Figure 
3.14).  While the soluble fraction from chloroform shows a purplish color as opposed to 
RED, the color could be due to induction of RED and actinorhodin (ACT) or just 
induction of ACT.  ACT is the compound for which S. coelicolor gets its name, as it 
changes color between blue and red in a pH-dependent manner (Bystrykh, et al., 1996).  
ACT is also a normal developmental process in S. coelicolor, but the media used in this 
study (GYM) contains glucose, which is known to repress ACT production (Tiffert, et 
al., 2008).  In Figures 3.5 and 3.6 there is a purple color before RED.  In Figure 3.5 the 
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purplish color is in the 106 spore dilution while in Figure 3.6 the purplish color appears 
at the 44hr time point before the plate is completely red at the 62hr time point.  As all of 
the organic solubility tests were done with the same amount of Dowex elution, they all 
should have the same amount of RED inducing activity either in the soluble or insoluble 
fractions.  The ethyl acetate and butanol fractions appear as if some of the inducing 
molecule was degraded, as there is faint inducing activity.  The inducing molecule from 
the chloroform fractionation test may have been split between the soluble and insoluble 
fractions, as there is induction in both of the fractions.   
 
 
 
Figure 3.14.  Solvent solubility tests of B. subtilis Dowex elutions plated against S. coelicolor.  Ten 100µL 
aliquots, of a typical wild type B. subtilis Dowex preparation, were separately dried and resuspended in 
1mL of various organic solvents.  The samples were spun down, pellets and supernatants both dried and 
resuspended in 100µL of water.  20µL of each fraction was plated against 107 spores of S. coelicolor.  
DCM – dichloromethane, MeCN – acetonitrile, IPA – isopropyl alcohol, MeOH – methanol. 
 
 86 
 
 
 As the inducing molecule was soluble and stable in methanol a series of 
fractionations of chloroform and methanol were pursued, so as to be able to fractionate 
the molecule using normal phase separation (Figure 3.15).  Presumably there is no 
soluble inducing activity in the chloroform fraction due to a lower concentration of the 
Dowex elution being used in this step than compared to Figure 3.14.  After using a ratio 
of chloroform to methanol of 90/10 there was some solubility of the inducing molecule, 
while at the 80/20 ratio there was complete solubility of the inducing compound.  Of 
interest is the phenomenon where induction of RED at 37hrs is correlated to accelerated 
spore formation at 61hrs, which is never seen on GYM.  Induction of early secondary 
metabolite production and sporulation has been seen in streptomycetes (Ueda, et al., 
2000, Igarashi, et al., 2001, Onaka, et al., 2001) and S. coelicolor in particular (Igarashi, 
et al., 2001, Perez, et al., 2011).  Accelerated development could lead to early induction 
of secondary metabolites then ultimately sporulation, so it is of interest whether 
induction of sporulation is directly tied to induction of RED or if the two processes are 
separated. 
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Figure 3.15.  Methanol/chloroform solubility of the inducing molecule.  Dowex elutions from wild type B. 
subtilis PY79 were reduced to dryness then resuspended in chloroform/methanol at 10% steps from 100% 
chloroform to 100% methanol.  The lower ratios are shown.  The 37 and 61 hour time points are shown. 
 
 
 Once conditions were determine to allow reverse phase and normal phase 
separation a variety of SPE cartridges were used: C8, C18, diol, cyano, NH2, and silica.  
C8, C18, cyano, and silica elutions are not shown, the molecule was able to bind the C18 
column, but eluted in the first fraction (data not shown).  Often times the compound 
would not bind to the columns if the Dowex elution was too concentrated.  To overcome 
this problem the Dowex elutions were pre-loaded onto the resin by taking the resin out 
of the cartridge, adding the Dowex elution too it, and drying under pressure.  The 
molecule eluted off of the various resins at different concentrations of solvent for each of 
the various resins Figures 3.16 (diol and NH2).  The inducing molecule was also able to 
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bind to silica resin, but it bound somewhat irreversibly, it did not elute off as well as for 
the diol or NH2 resins (data not shown). 
 
 
 
Figure 3.16.  Dowex elutions of wild type B. subtilis PY79 applied to diol and NH2 resins eluted and 
applied to S. coelicolor M145.  After drying the Dowex elutions onto the resin the samples were eluted off 
in increasing 10ml steps of methanol/chloroform, starting at 0% methanol/100% chloroform (when resin 
was removed from the rotovap and added into the column, labeled as FT) then 10% increases in the 
methanol concentration through 100% methanol/0% chloroform.  A final 30ml methanol wash of the resin 
was performed to elute anything stuck to the column. 
 
 
 Figure 3.16 shows elution characteristics of the inducing molecule after a Dowex 
elution was pre-adsorbed to the two resins (diol and NH2) under pressure, and then 
eluted off.  It appears as if the inducing compound eluted off of the diol resin at 30% 
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methanol/70% chloroform.  At the 40% and 50% fractions of methanol/chloroform there 
could have been another molecule eluting off which inhibits the production of pigmented 
secondary metabolites.  Previously we had drawn a link between bacilysin and DasR.  
Bacilysin inhibits glmS, responsible for producing Glc-N-6P (Chmara, 1985). Glc-N-6P 
binds to DasR, preventing it from repressing secondary metabolism (Rigali, et al., 2008).  
By preventing the production of Glc-N-6P bacilysin could be repressing antibiotic 
biosynthesis in neighboring organisms. 
 
3.3.8 RED may autoinduce through a quorum sensing mechanism 
 Finally, through repeated experiments the observation was made that RED 
induction spreads throughout a plate of S. coelicolor.  If multiple samples were spotted 
on the same plate of S. coelicolor there would often be a larger induction effect than if 
the samples were spotted on separate plates.  This phenomenon may be a result of a 
quorum-sensing mechanism wherein RED triggers production of γ-butyrolactone or if 
RED is a quorum-sensing molecule involved in inducing production of itself.  Figure 
3.17, panel A, shows the flow through, 5% methanol, and 10% methanol fractions from 
a wild type B. subtilis PY79 Dowex elution applied to a C18 SPE cartridge and overlaid 
on the same plate of S. coelicolor.  There is extensive induction of RED throughout most 
of the plate.  At the same time, on separate plates of S. coelicolor, the same fractions 
were also plated but only one sample was spotted on a plate (Figure 3.17, panel B), as 
opposed to the three that were spotted on the same plate seen in Figure 3.17A.  When 
plating the same fractions on separate plates of S. coelicolor the induction of RED was 
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limited to the through flow from the column, not spread throughout the plate.  This 
phenomenon is not isolated.  When looking at plates from the solvent solubility 
experiments (shown in Figure 3.14), which had multiple samples spotted on each plate, 
there appears to be induction between fractions which had high levels of the inducing 
molecule.  In Figure 3.17, panel C, there is induction between samples plated which had 
the inducer (Figure 3.17C top image) but the induction is not seen between samples with 
lower levels of the inducing molecule (Figure 3.17C bottom panel).  This could be due to 
a quorum sensing mechanism involved in the induction of RED (Williamson, et al., 
2006) wherein RED induces production of itself or factors involved in RED induction 
are also secreted, inducing RED locally.  An alternative explanation could be that the 
induction of RED causes what nutrients remain in the media to be used up in the 
production of RED.  Once streptomycetes sense a lack of nutrients (or unfavorable 
conditions) and they undergo morphogenesis to produce spores ensuring further 
generations, this process involves the production of secondary metabolites, such as RED. 
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Figure 3.17.  Possible quorum sensing induction of RED.  Dowex elutions from wild type B. subtilis PY79 
were applied to a C18 SPE cartridge, and fractions collected, the flow through (FT), 5% methanol/water, 
and 10% methanol/water fractions are shown plated on the same plate (panel A), and zoomed in on where 
the samples were spotted (panel B top images).  The same samples were plated at the same time on 
different plates (panel B bottom images).  The localized induction of RED between inducing samples is 
seen on plates from Figure 3.14, when looked at the whole plate. 
 
 
 To avoid quorum-sensing induction of RED as a result of sub-inducing 
concentrations of an inducing molecule another strategy to monitor induction of RED 
could be employed.  A previous study looking at the induction of ACT with a synthetic 
chemical compound library used liquid cultures in 96-well plates (Craney, et al., 2012).  
This method uses fewer spores, less media, less inducing compounds, and enables 
samples to be separated from each other, resulting in a more reliable, less costly 
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experiment when screening for the inducing compound.  Furthermore, induction could 
be quantified through colorimetric methods (i.e. using a plate reader to measure 
absorbance of induced RED compounds).  The method would have to be optimized, but 
in the end would result in cheaper experiments with greater reproducibility. 
 
3.4 Future Directions 
While purified bacilysin did not induce RED, the genetics indicated that there is 
a link between bacilysin production and the inducing molecule (Figure 3.2 shows ∆bacB 
PY79 vs. S. coelicolor without induction of RED).  When lyophilized supernatants from 
WT PY79 and ∆bacB PY79 were applied to S. coelicolor, WT supernatants induced 
early production of RED in S. coelicolor whereas ∆bacB supernatants did not (Figure 
3.3).  To reproduce induction of RED from lyophilized supernatants but without salt, 
proteins, or other cell debris, the Dowex step from the purification of bacilysin showed 
that wild type extracts but not ΔbacB induced RED.  Furthermore, the fractions which 
induced RED also caused other developmental processes to proceed earlier than normal 
(Figure 3.6).  This includes early production of a blue pigment actinorhodin (ACT) (data 
not shown) as well as early sporulation, seen through the white pigment characteristic of 
spores (Figure 3.6).  Accelerated morphogenesis causing early production of secondary 
metabolites (RED and ACT) as well as rapid sporulation could be from a build-up of 
internal signaling molecules produced early as a result of RED induction, or it could be 
that the inducer of RED is targeting a regulator which also controls these processes in S. 
coelicolor.  Developmental processes in S. coelicolor are linked through multiple layers 
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of regulation (Bibb, 2005), so induction of RED could conceivably impact other 
processes.  A recent study also reported that B. subtilis induced early ACT production 
and sporulation (Perez, et al., 2011), so the inducing molecule of RED could be tied to a 
regulator responsible for all three. 
Identifying the molecule(s) involved in induction of RED will allow for 
determining the mechanism of induction in S. coelicolor.  If the induction is not just a 
by-product of a metabolic flux, and there is a specific mechanism then it could be 
conserved amongst streptomycetes.  Induction of a specific metabolite (RED) by an 
unknown molecule from another organism may yield a tool to elicit cryptic metabolites 
from streptomycetes. 
Several studies have noted the increase in RED from the addition of various 
compounds (Onaka, et al., 2001, Craney, et al., 2012) or conditioned media (Luti & 
Mavituna, 2011).  None of these works address a specific mechanism of induction of 
RED.  Furthermore, there is no report of an identified natural product which induces 
production of RED.  How would S. coelicolor respond to a neighboring organism?  We 
hypothesize induction is not caused by affecting a specific regulator of RED.  A defense 
mechanism where S. coelicolor turns on RED early against one particular molecule 
produced probably only by a handful of organisms would be very costly.  S. coelicolor 
would have to have tens to hundreds of such regulators to compete with its neighbors.  
Instead, we hypothesize that induction of RED is due to a stress-sensing mechanism 
caused by an altered metabolic flux in S. coelicolor.  An altered metabolic flux could be 
sensed through a general stress-sensing mechanism, wherein an essential primary 
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metabolite is no longer available and the cell turns on developmental processes as a 
result, similar to the onset of stationary phase in other bacteria.  Alternatively the 
inducing molecule might relieve repression of regulators of developmental processes, 
affecting a metabolite-responsive GntR-like repressor (Hoskisson & Rigali, 2009).  
Regardless of which metabolite is the inducer of RED, the mechanism of induction will 
need to be further characterized.  Establishing the genetics required for the mechanism 
of induction will come from mutagenizing S. coelicolor then applying the inducer 
molecule to see which mutations no longer give an early induction of RED.   
Many technical issues of transposition in streptomycetes have been overcome in 
recent years with successful identification of many regulators or other proteins involved 
in antibiotic biosynthesis in S. coelicolor coming from transposon mutagenesis (Hillerich 
& Westpheling, 2006, Hoskisson, et al., 2006, Ou, et al., 2009, Petzke & Luzhetskyy, 
2009, Lamb, et al., 2010, Fernandez-Martinez, et al., 2011, Hull, et al., 2012).  Chemical 
or UV mutagenesis of S. coelicolor to search for factors regulating the early induction of 
RED is one possibility to consider and has been done with other streptomycetes (Yu, et 
al., 2011).  All types of mutagenesis will give a background of mutations in the RED 
gene cluster, but transposon mutagenesis will allow for the easier identification of where 
the mutations occur in the genome.  This is due to the ability to recover plasmids from 
mutants with transposon insertions or through the use of arbitrary PCR linked to a 
sequence in the transposon.  
Relatively simple experiments to determine conditions involved in the early 
induction of RED would be to grow S. coelicolor under different nutritional conditions 
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then adding the molecule.  This could help determine if carbon, phosphorous or nitrogen 
limitations activate or repress the phenotype induced by the inducing molecule in the 
initial screen.  The induction of RED might be blocked by regulators expressed as a 
result of different experimental conditions than those used in the initial screen.  For 
instance, actinorhodin is repressed by glucose (van Wezel & McDowall, 2011), since the 
initial screen was done on GYM (glucose, yeast extract, malt extract) any induction of 
actinorhodin would have been suppressed.  Determining which nutritional conditions 
yield induction of RED in response to the metabolite could narrow down the window of 
regulators involved.  This would allow us to limit the potential regulators to those that 
are expressed under a particular set of conditions which induce RED when the inducer is 
present but not when the inducer is absent. 
Identifying the optimal conditions where early induction of RED is clearly turned 
off in the absence of the inducer molecule would also make a microarray experiment 
easier to interpret.  A microarray experiment, comparing WT S. coelicolor with or 
without the inducing molecule could identify potential regulators involved in the early 
production of RED.  Up or down regulation of putative regulators, at a time when RED 
is induced early with the inducing molecule but not without the molecule, would narrow 
the pool of potential regulators affected by the inducer molecule.  A comparison with 
studies that have already identified altered transcription of putative regulators when RED 
is turned on could further elicit which ones are involved in the early induction of RED 
(Huang, et al., 2001, Hesketh, et al., 2007, Lee, et al., 2010).  Further experiments 
comparing altered transcriptional profiles when tested against the metabolite amongst 
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various streptomycetes versus a S. coelicolor microarray could identify a common 
regulator within the various species (Kirby, et al., 2011). 
 There will continue to be a growing need for new bioactive compounds, 
especially those with novel scaffolds.  Furthermore the pharmaceutical industry has left 
behind natural product discovery and all but abandoned antibiotic research in favor of 
combinatorial chemistry (Baltz, 2006).  Previous drug discovery focused on the low 
throughput practice of fermentation followed by bioassays for activity.  This approach 
stopped yielding as many new compounds as many of the same compounds were 
rediscovered.  For instance streptomycin is produced by ~1% of streptomycetes, making 
its rediscovery rate quite high, whereas daptomycin is only produced in ~10-7 of 
streptomycetes (Baltz, 2008).  The traditional approach to discovering secondary 
metabolites has ‘plucked the low hanging fruit,’ most often coming up with generic 
compounds like streptomycin while rarely producing unique compounds like 
daptomycin.  With traditional fermentation techniques rediscovering the same 
metabolites a new approach should be taken.  In light of the largely untapped genetic 
potential of streptomycetes to produce secondary metabolites, there is growing 
momentum to try to elicit these cryptic metabolites. 
 The goal through searching for an inducer of RED is ultimately to elicit cryptic 
metabolites.  Two previous studies have identified two molecules produced by 
streptomycetes which induce other streptomycetes to produce antibiotics, goadsporin 
and promomycin (Onaka, et al., 2001, Amano, et al., 2010).  Our attempt to find a 
general inducing molecule falls along these story lines yet is different for two reasons.  
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First, our inducing molecule is not produced by a streptomycete.  Therefore S. coelicolor 
is responding to a neighboring organism rather than an ancient quorum-sensing signal.  
For this reason we hypothesize that our signaling molecule would affect many 
streptomycetes.  Mounting a defense response to a neighboring organism would seem to 
be more conserved than retaining a receptor for an ancient signal.  The ability to respond 
to a stress caused by a neighboring organism illustrates that any molecule induced would 
probably have a bioactive property, either to negate some sort of stress or to have an 
effect on the neighboring organism.  Looking for molecules with bioactive properties 
would be more productive in terms of drug discovery than looking for the induced 
production of streptomycete hormones, which may just serve to signal environmental 
conditions. 
The second major difference, unlike the other two studies of inducing molecules, 
is that the responding strain used in this study, S. coelicolor, is a sequenced model 
organism for streptomycetes.  This will allow a mechanism for elicitation of secondary 
metabolites, to use for rational elicitation of secondary metabolites from other 
streptomycetes.  Once an inducing compound is identified testing it against other 
streptomycetes would determine if there is induction of metabolites which would not 
otherwise be produced in monoculture.   
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CHAPTER IV  
 
CONCLUSIONS 
 
The overall goal of this thesis was to identify the cause of surfactin hydrolysis by 
S. Mg1.  By analyzing secreted proteins, cloning and expressing in a heterologous 
system, followed by in vitro assays, a candidate enzyme was discovered.  This study is 
the first time an enzymatic function has been proposed through MALDI-IMS and then 
subsequently identified to a protein.  The enzymatic mechanism hypothesized was that 
of degrading a xenobiotic.  That S. Mg1 degrades a foreign compound, with antagonistic 
properties against streptomycetes, shows that the surfactin hydrolase enzyme is a 
resistance mechanism to antibiotics, giving S. Mg1 an advantage over other 
streptomycetes when surfactin is present. 
Further characterization of the enzyme showed that the hydrolase was capable of 
degrading multiple compounds and that it changed substrate specificity with the addition 
of a divalent metal cation is also interesting.  Rather than losing substrate specificity for 
two both molecules that it was previously able to hydrolyze, it lost it for one molecule 
but not the other, surfactin and plipastatin, respectively.  Future characterization of this 
enzyme could further determine if the enzyme has more substrates, suggesting its 
evolution against many neighboring organisms.  Biofilm formation by B. subtilis is 
required for some plants to be protected against pathogens.  As surfactin is required for 
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biofilm film formation, the surfactin hydrolase could have more roles in the environment 
than described in this work. 
The second project presented was elicitation of undecylprodigiosin by B. subtilis.  
While purified bacilysin did not induce RED, there is a genetic link between the deletion 
of bacB and decreased induction of RED.  Fractions of B. subtilis extracts which induced 
RED also caused other developmental processes to proceed earlier than normal. This 
could be from a build-up of internal signaling molecules produced early as a result of 
RED induction, or it could be that the inducer of RED is targeting a regulator which also 
controls these processes in S. coelicolor.  Identifying the molecule(s) involved in 
induction of RED will allow for determining the mechanism of induction in S. 
coelicolor, which could lead to discoveries in inducing cryptic metabolites in other 
streptomycetes.  The identification of new molecules with antibacterial properties is 
essential for public health, as only the continual discovery of new antibiotics will 
prevent antibiotic resistance from returning infectious diseases as the number one killer 
of humans. 
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